1
|
Oliveira N, Cañellas I, Fuertes A, Pascual S, González I, Montes F, Sixto H. Beyond biomass production: Enhancing biodiversity while capturing carbon in short rotation coppice poplar plantations. Sci Total Environ 2024; 933:172932. [PMID: 38703860 DOI: 10.1016/j.scitotenv.2024.172932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/09/2024] [Revised: 04/06/2024] [Accepted: 04/30/2024] [Indexed: 05/06/2024]
Abstract
Biodiversity is essential for the functioning of ecosystems and the provision of services. In recent years, the role of plantations in mitigating climate change through carbon sequestration has been highlighted. In the Mediterranean area, high-density poplar plantations in short-rotation with resprouting management (SRC) have been established for biomass purposes on mostly irrigated agricultural land, coexisting with rainfed and irrigated agricultural crops. This study aims to assess the contribution of these plantations to this type of agroforest ecosystem in terms of biodiversity. For this purpose, both flora and fauna diversity were evaluated both within and outside of the plantation. Additionally, the accumulated carbon in the biomass, as well as in the accompanying vegetation within the plantation, was assessed. Different indices were used to evaluate both the intrinsic diversity of the forest plantation and the degree of substitution and complementarity between the different communities of the landscape. Our findings reveal distinct biodiversity patterns in the land-use scenarios sampled. Specifically, we observed significantly higher flora-species richness in SRC plantations than in the adjacent agricultural land, whereas fauna richness showed a similar but slightly higher level in the forested area. A moderate level of complementarity between land uses was found for insects and mammals (around 45 %), contrasting with high complementarity for birds (87 %) and flora (90 %). This suggests substantial turnover and replacement among these ecological environments. Our results indicate that a second rotation (4 year) plantation could accumulate a total of 61.6 Mg C ha-1, and even though adventitious flora represents <2 % of the total carbon accumulated, its importance in providing ecosystem services is considerable. Hence, these findings evidence the fact that SRC poplar plantations can enhance biodiversity in Mediterranean agroforest ecosystems and actively contribute to various provisioning ecosystem services, including carbon sequestration, reflecting a multi-objective approach that extends beyond biomass production.
Collapse
Affiliation(s)
- N Oliveira
- Institute of Forest Sciences (INIA, CSIC), Crta. de A Coruña km 7.5, 28040 Madrid, Spain.
| | - I Cañellas
- Institute of Forest Sciences (INIA, CSIC), Crta. de A Coruña km 7.5, 28040 Madrid, Spain
| | - A Fuertes
- Institute of Forest Sciences (INIA, CSIC), Crta. de A Coruña km 7.5, 28040 Madrid, Spain
| | - S Pascual
- Entomology Group, Plant Protection Department, INIA, CSIC, Ctra. de A Coruña km 7.5, 28040 Madrid, Spain
| | - I González
- Institute of Forest Sciences (INIA, CSIC), Crta. de A Coruña km 7.5, 28040 Madrid, Spain
| | - F Montes
- Institute of Forest Sciences (INIA, CSIC), Crta. de A Coruña km 7.5, 28040 Madrid, Spain
| | - H Sixto
- Institute of Forest Sciences (INIA, CSIC), Crta. de A Coruña km 7.5, 28040 Madrid, Spain
| |
Collapse
|
2
|
Mesonero F, Zabana Y, Fernández-Clotet A, Leo-Carnerero E, Caballol B, Núñez-Ortiz A, García MJ, Bertoletti F, Mínguez A, Suris G, Casis B, Ferreiro-Iglesias R, Calafat M, Jiménez I, Miranda-Bautista J, Lamuela LJ, Fajardo I, Torrealba L, Nájera R, Sáiz-Chumillas RM, González I, Vicuña M, García-Morales N, Gutiérrez A, López-García A, Benítez JM, Rubín de Célix C, Tejido C, Brunet E, Hernández-Camba A, Suárez C, Rodríguez-Lago I, Piqueras M, Castaño A, Ramos L, Sobrino A, Rodríguez-Grau MC, Elosua A, Montoro M, Baltar R, Huguet JM, Hermida B, Caballero-Mateos A, Sánchez-Guillén L, Bouhmidi A, Pajares R, Baston-Rey I, López-Sanromán A, Albillos A, Barreiro-de Acosta M. Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU. Therap Adv Gastroenterol 2024; 17:17562848241234476. [PMID: 38445247 PMCID: PMC10913517 DOI: 10.1177/17562848241234476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Accepted: 02/02/2024] [Indexed: 03/07/2024] Open
Abstract
Background The usefulness of thiopurines has been poorly explored in pouchitis and other pouch disorders. Objective To evaluate the effectiveness and safety of azathioprine as maintenance therapy in inflammatory pouch disorders. Design This was a retrospective and multicentre study. Methods We included patients diagnosed with inflammatory pouch disorders treated with azathioprine in monotherapy. Effectiveness was evaluated at 1 year and in the long term based on normalization of stool frequency, absence of pain, faecal urgency or fistula discharge (clinical remission), or any improvement in these symptoms (clinical response). Endoscopic response was evaluated using the Pouchitis Disease Activity Index (PDAI). Results In all, 63 patients were included [54% males; median age, 49 (28-77) years]. The therapy was used to treat pouchitis (n = 37) or Crohn's disease of the pouch (n = 26). The rate of clinical response, remission and non-response at 12 months were 52%, 30% and 18%, respectively. After a median follow-up of 23 months (interquartile range 11-55), 19 patients (30%) were in clinical remission, and 45 (66%) stopped therapy. Endoscopic changes were evaluated in 19 cases. PDAI score decreased from 3 (range 2-4) to 1 (range 0-3). In all, 21 patients (33%) presented adverse events and 16 (25%) needed to stop therapy. Conclusion Azathioprine may be effective in the long term for the treatment of inflammatory pouch disorders and could be included as a therapeutic option.
Collapse
Affiliation(s)
- Francisco Mesonero
- Inflammatory Bowel Disease Unit, Department of Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, Cra. Colmenar km 9.1, Madrid 28034, Spain
| | - Yamile Zabana
- Hospital Universitario Mútua Terrassa, Terrassa, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | - Agnès Fernández-Clotet
- Hospital Clínic Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | | | - Berta Caballol
- Hospital Clínic Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | | | - María José García
- Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain
| | | | | | - Gerard Suris
- Hospital Universitario de Bellvitge, Barcelona, Spain
| | - Begoña Casis
- Hospital Universitario 12 de Octubre, Madrid, Spain
| | | | - Margalida Calafat
- Hospital Universitario Germans Trias i Pujol, Badalona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | - Itxaso Jiménez
- Hospital Universitario de Galdakao, Biocruces Bizkaia Health Research Institute, Galdakao, Spain
| | | | | | | | | | | | | | | | | | | | - Ana Gutiérrez
- Hospital General Universitario Alicante Doctor Balmis (Alicante), Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | - Alicia López-García
- Hospital del Mar i Institut Mar d’Investigacions Mediques (IMIM), Barcelona, Spain
| | | | - Cristina Rubín de Célix
- Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | - Coral Tejido
- Complejo Hospitalario Universitario Ourense, Ourense, Spain
| | - Eduard Brunet
- Hospital Universitari Parc Taulí, Sabadell, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | | | - Cristina Suárez
- Hospital Universitario La Paz, Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain
| | - Iago Rodríguez-Lago
- Hospital Universitario de Galdakao, Biocruces Bizkaia Health Research Institute, Galdakao, Spain
| | | | | | - Laura Ramos
- Hospital Universitario de Canarias, Santa Cruz, Spain
| | - Ana Sobrino
- Hospital General Universitario Ciudad Real, Ciudad Real, Spain
| | | | | | | | - Ruth Baltar
- Hospital Universitario Álava, Vitoria, Spain
| | | | | | | | | | | | - Ramón Pajares
- Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain
| | - Iria Baston-Rey
- Hospital Clínico Universitario Santiago, Santiago de Compostela, Spain
| | | | | | | |
Collapse
|
3
|
Esteban-Martos A, Brokate-Llanos AM, Real LM, Melgar-Locatelli S, de Rojas I, Castro-Zavala A, Bravo MJ, Mañas-Padilla MDC, García-González P, Ruiz-Galdon M, Pacheco-Sánchez B, Polvillo R, Rodriguez de Fonseca F, González I, Castilla-Ortega E, Muñoz MJ, Rivera P, Reyes-Engel A, Ruiz A, Royo JL. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer's Disease. Int J Mol Sci 2023; 24:12079. [PMID: 37569459 PMCID: PMC10418421 DOI: 10.3390/ijms241512079] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2023] [Revised: 07/24/2023] [Accepted: 07/25/2023] [Indexed: 08/13/2023] Open
Abstract
Genome-wide association studies (GWAS) constitute a powerful tool to identify the different biochemical pathways associated with disease. This knowledge can be used to prioritize drugs targeting these routes, paving the road to clinical application. Here, we describe DAGGER (Drug Repositioning by Analysis of GWAS and Gene Expression in R), a straightforward pipeline to find currently approved drugs with repurposing potential. As a proof of concept, we analyzed a meta-GWAS of 1.6 × 107 single-nucleotide polymorphisms performed on Alzheimer's disease (AD). Our pipeline uses the Genotype-Tissue Expression (GTEx) and Drug Gene Interaction (DGI) databases for a rational prioritization of 22 druggable targets. Next, we performed a two-stage in vivo functional assay. We used a C. elegans humanized model over-expressing the Aβ1-42 peptide. We assayed the five top-scoring candidate drugs, finding midostaurin, a multitarget protein kinase inhibitor, to be a protective drug. Next, 3xTg AD transgenic mice were used for a final evaluation of midostaurin's effect. Behavioral testing after three weeks of 20 mg/kg intraperitoneal treatment revealed a significant improvement in behavior, including locomotion, anxiety-like behavior, and new-place recognition. Altogether, we consider that our pipeline might be a useful tool for drug repurposing in complex diseases.
Collapse
Affiliation(s)
- Alvaro Esteban-Martos
- Department of Surgery, Biochemistry and Immunology, School of Medicine, University of Malaga, Boulevard Louis Pasteur s/n, 29071 Malaga, Spain; (A.E.-M.); (L.M.R.); (M.J.B.); (M.R.-G.); (I.G.); (A.R.-E.)
| | - Ana Maria Brokate-Llanos
- Departamento de Biología Molecular e Ingeniería Bioquímica, Centro Andaluz de Biología del Desarrollo (CABD), Universidad Pablo de Olavide (UPO), UPO/CSIC/JA, Ctra Utrera Km1, 41013 Sevilla, Spain; (A.M.B.-L.); (R.P.); (M.J.M.)
| | - Luis Miguel Real
- Department of Surgery, Biochemistry and Immunology, School of Medicine, University of Malaga, Boulevard Louis Pasteur s/n, 29071 Malaga, Spain; (A.E.-M.); (L.M.R.); (M.J.B.); (M.R.-G.); (I.G.); (A.R.-E.)
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain
| | - Sonia Melgar-Locatelli
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Malaga, Spain; (S.M.-L.); (A.C.-Z.); (M.d.C.M.-P.); (B.P.-S.); (F.R.d.F.); (E.C.-O.); (P.R.)
- Departamento de Psicobiología y Metodología de las Ciencias del Comportamiento, Facultad de Psicología, Universidad de Málaga, 29071 Malaga, Spain
| | - Itziar de Rojas
- Research Center and Memory Clinic, Ace Alzheimer Center Barcelona—Universitat Internacional de Catalunya, 08017 Barcelona, Spain; (I.d.R.); (P.G.-G.); (A.R.)
- Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), National Institute of Health Carlos III, 28029 Madrid, Spain
| | - Adriana Castro-Zavala
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Malaga, Spain; (S.M.-L.); (A.C.-Z.); (M.d.C.M.-P.); (B.P.-S.); (F.R.d.F.); (E.C.-O.); (P.R.)
- Departamento de Psicobiología y Metodología de las Ciencias del Comportamiento, Facultad de Psicología, Universidad de Málaga, 29071 Malaga, Spain
| | - Maria Jose Bravo
- Department of Surgery, Biochemistry and Immunology, School of Medicine, University of Malaga, Boulevard Louis Pasteur s/n, 29071 Malaga, Spain; (A.E.-M.); (L.M.R.); (M.J.B.); (M.R.-G.); (I.G.); (A.R.-E.)
| | - Maria del Carmen Mañas-Padilla
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Malaga, Spain; (S.M.-L.); (A.C.-Z.); (M.d.C.M.-P.); (B.P.-S.); (F.R.d.F.); (E.C.-O.); (P.R.)
- Departamento de Psicobiología y Metodología de las Ciencias del Comportamiento, Facultad de Psicología, Universidad de Málaga, 29071 Malaga, Spain
| | - Pablo García-González
- Research Center and Memory Clinic, Ace Alzheimer Center Barcelona—Universitat Internacional de Catalunya, 08017 Barcelona, Spain; (I.d.R.); (P.G.-G.); (A.R.)
- Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), National Institute of Health Carlos III, 28029 Madrid, Spain
| | - Maximiliano Ruiz-Galdon
- Department of Surgery, Biochemistry and Immunology, School of Medicine, University of Malaga, Boulevard Louis Pasteur s/n, 29071 Malaga, Spain; (A.E.-M.); (L.M.R.); (M.J.B.); (M.R.-G.); (I.G.); (A.R.-E.)
| | - Beatriz Pacheco-Sánchez
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Malaga, Spain; (S.M.-L.); (A.C.-Z.); (M.d.C.M.-P.); (B.P.-S.); (F.R.d.F.); (E.C.-O.); (P.R.)
- Unidad de Gestion Clinica de Salud Mental, Hospital Universitario Regional de Malaga, 29010 Malaga, Spain
| | - Rocío Polvillo
- Departamento de Biología Molecular e Ingeniería Bioquímica, Centro Andaluz de Biología del Desarrollo (CABD), Universidad Pablo de Olavide (UPO), UPO/CSIC/JA, Ctra Utrera Km1, 41013 Sevilla, Spain; (A.M.B.-L.); (R.P.); (M.J.M.)
| | - Fernando Rodriguez de Fonseca
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Malaga, Spain; (S.M.-L.); (A.C.-Z.); (M.d.C.M.-P.); (B.P.-S.); (F.R.d.F.); (E.C.-O.); (P.R.)
- Unidad de Gestion Clinica de Salud Mental, Hospital Universitario Regional de Malaga, 29010 Malaga, Spain
| | - Irene González
- Department of Surgery, Biochemistry and Immunology, School of Medicine, University of Malaga, Boulevard Louis Pasteur s/n, 29071 Malaga, Spain; (A.E.-M.); (L.M.R.); (M.J.B.); (M.R.-G.); (I.G.); (A.R.-E.)
| | - Estela Castilla-Ortega
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Malaga, Spain; (S.M.-L.); (A.C.-Z.); (M.d.C.M.-P.); (B.P.-S.); (F.R.d.F.); (E.C.-O.); (P.R.)
- Departamento de Psicobiología y Metodología de las Ciencias del Comportamiento, Facultad de Psicología, Universidad de Málaga, 29071 Malaga, Spain
| | - Manuel J. Muñoz
- Departamento de Biología Molecular e Ingeniería Bioquímica, Centro Andaluz de Biología del Desarrollo (CABD), Universidad Pablo de Olavide (UPO), UPO/CSIC/JA, Ctra Utrera Km1, 41013 Sevilla, Spain; (A.M.B.-L.); (R.P.); (M.J.M.)
| | - Patricia Rivera
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Malaga, Spain; (S.M.-L.); (A.C.-Z.); (M.d.C.M.-P.); (B.P.-S.); (F.R.d.F.); (E.C.-O.); (P.R.)
- Unidad de Gestion Clinica de Salud Mental, Hospital Universitario Regional de Malaga, 29010 Malaga, Spain
| | - Armando Reyes-Engel
- Department of Surgery, Biochemistry and Immunology, School of Medicine, University of Malaga, Boulevard Louis Pasteur s/n, 29071 Malaga, Spain; (A.E.-M.); (L.M.R.); (M.J.B.); (M.R.-G.); (I.G.); (A.R.-E.)
| | - Agustin Ruiz
- Research Center and Memory Clinic, Ace Alzheimer Center Barcelona—Universitat Internacional de Catalunya, 08017 Barcelona, Spain; (I.d.R.); (P.G.-G.); (A.R.)
- Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), National Institute of Health Carlos III, 28029 Madrid, Spain
| | - Jose Luis Royo
- Department of Surgery, Biochemistry and Immunology, School of Medicine, University of Malaga, Boulevard Louis Pasteur s/n, 29071 Malaga, Spain; (A.E.-M.); (L.M.R.); (M.J.B.); (M.R.-G.); (I.G.); (A.R.-E.)
| |
Collapse
|
4
|
Recio V, González I, Tarragó D. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance. Virol J 2023; 20:153. [PMID: 37464399 PMCID: PMC10355059 DOI: 10.1186/s12985-023-02127-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Accepted: 07/11/2023] [Indexed: 07/20/2023] Open
Abstract
Resistant CMV infections are challenging complications after SOT and HSCT. Prompt recognition of ARMs is imperative for appropriate therapy. 108 plasma samples from 96 CMV + transplant recipients with suspected resistance were analysed in CNM in a retrospective nationwide study from January 2018 to July 2022 for resistance genotyping. ARMs in UL97 and UL54 were found in 26.87% (18/67) and 10.60% (7/66) of patients, respectively. Patients' ARM distribution in UL97 was as follows: L595S n = 3; L595S/M460I n = 1; L595S/N510S n = 1; L595W n = 1; C603W n = 4; A594V n = 3; A594E n = 1; C607Y n = 1; L397R/T409M/H411L/M460I n = 1; L397I n = 1; H520Q n = 1; four patients showed ARMs in UL54 as well (F412C n = 1; T503I n = 2; P522S n = 1), whereas three patients exhibited ARMs in UL54 only (L501I/T503I/L516R/A834P n = 1; A987G n = 2). L516R in UL54 and L397R/I and H411L in UL97 have been found for the first time in a clinical sample. L595S/W was the most prevalent ARM found to lend resistance to GCV. In UL54 all ARMs lent resistance to GCV and CDV. In addition, A834P, found in one patient, also lent resistance to FOS. CMV load did not differ significantly in patients with or without ARMs, and no differences were found either between patients with ARMs in UL97 or in UL97 and UL54. Despite extensive use of classical antivirals for the treatment of CMV infection after HSCT and SOT, ARMs occurred mainly in viral UL97 kinase, which suggests that CDV and mostly FOS continue to be useful alternatives to nucleoside analogues after genotypic detection of ARMs.
Collapse
Affiliation(s)
- Vanessa Recio
- Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda- Pozuelo km 2, Madrid, 28220, Spain
| | - Irene González
- Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda- Pozuelo km 2, Madrid, 28220, Spain
| | - David Tarragó
- Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda- Pozuelo km 2, Madrid, 28220, Spain.
- CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
| |
Collapse
|
5
|
Esteller-Cucala P, Palmada-Flores M, Kuderna LFK, Fontsere C, Serres-Armero A, Dabad M, Torralvo M, Faella A, Ferrández-Peral L, Llovera L, Fornas O, Julià E, Ramírez E, González I, Hecht J, Lizano E, Juan D, Marquès-Bonet T. Y chromosome sequence and epigenomic reconstruction across human populations. Commun Biol 2023; 6:623. [PMID: 37296226 PMCID: PMC10256797 DOI: 10.1038/s42003-023-05004-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Accepted: 05/31/2023] [Indexed: 06/12/2023] Open
Abstract
Recent advances in long-read sequencing technologies have allowed the generation and curation of more complete genome assemblies, enabling the analysis of traditionally neglected chromosomes, such as the human Y chromosome (chrY). Native DNA was sequenced on a MinION Oxford Nanopore Technologies sequencing device to generate genome assemblies for seven major chrY human haplogroups. We analyzed and compared the chrY enrichment of sequencing data obtained using two different selective sequencing approaches: adaptive sampling and flow cytometry chromosome sorting. We show that adaptive sampling can produce data to create assemblies comparable to chromosome sorting while being a less expensive and time-consuming technique. We also assessed haplogroup-specific structural variants, which would be otherwise difficult to study using short-read sequencing data only. Finally, we took advantage of this technology to detect and profile epigenetic modifications among the considered haplogroups. Altogether, we provide a framework to study complex genomic regions with a simple, fast, and affordable methodology that could be applied to larger population genomics datasets.
Collapse
Affiliation(s)
- Paula Esteller-Cucala
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
| | - Marc Palmada-Flores
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Lukas F K Kuderna
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Claudia Fontsere
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Aitor Serres-Armero
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Marc Dabad
- CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Baldiri i Reixac 4, Barcelona, Spain
| | - María Torralvo
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Armida Faella
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Luis Ferrández-Peral
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Laia Llovera
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Oscar Fornas
- Centre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain
- Universitat Pompeu Fabra (UPF), Doctor Aiguader 88, Barcelona, Spain
| | - Eva Julià
- Centre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain
| | - Erika Ramírez
- Centre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain
| | - Irene González
- Centre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain
| | - Jochen Hecht
- Centre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain
| | - Esther Lizano
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
- Institut Català de Paleontologia Miquel Crusafont, Universitat Autònoma de Barcelona, Edifici ICTA-ICP, Cerdanyola del Vallès, Spain
| | - David Juan
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain
| | - Tomàs Marquès-Bonet
- Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
- CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Baldiri i Reixac 4, Barcelona, Spain.
- Universitat Pompeu Fabra (UPF), Doctor Aiguader 88, Barcelona, Spain.
- Institut Català de Paleontologia Miquel Crusafont, Universitat Autònoma de Barcelona, Edifici ICTA-ICP, Cerdanyola del Vallès, Spain.
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig Lluís Companys 23, Barcelona, Spain.
| |
Collapse
|
6
|
Redondo S, De Dios A, Gomis-Pastor M, Esquirol A, Aso O, Triquell M, Moreno ME, Riba M, Ruiz J, Blasco A, Tobajas E, González I, Sierra J, Martino R, García-Cadenas I. Feasibility of a new model of care for allogeneic stem cell transplantation recipients facilitated by eHealth: The MY-Medula pilot study. Transplant Cell Ther 2023:S2666-6367(23)01175-2. [PMID: 36948273 DOI: 10.1016/j.jtct.2023.03.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Revised: 03/13/2023] [Accepted: 03/13/2023] [Indexed: 03/24/2023]
Abstract
BACKGROUND The use of allogeneic stem cell transplantation (allo-SCT) for the treatment of hematologic diseases is steadily increasing. However, allo-SCT has the downside of causing considerable treatment-related morbidity and mortality. Mobile technology applied to healthcare (mHealth) has proven to be a cost-effective strategy to improve care and offer new services to people with multimorbidity, but there are few data on its usefulness in allo-SCT recipients. OBJECTIVE The aim of this report was to describe a new integrated healthcare model facilitated by an mHealth platform, named EMMASalud-MY-Medula, and to report the results of a le. STUDY DESIGN The MY-Medula platform development approach consisted of 4 phases. Firstly, patient and healthcare professional needs were identified and technological development and pre-testing tests were conducted (phases 1-3, January 2016-March 2021). Then, a non-randomized, prospective, observational, single-center pilot study was conducted (October 2021-January 2022) at the adult Stem Cell Transplant Unit of a tertiary university hospital. RESULTS Twenty-eight volunteer allo-SCT recipients were included in the pilot study. Fifty percent were outpatients in the first-year post-SCT and the remaining 50% were affected by steroid-dependent graft-versus-host disease (SR-GVHD). All patients used MY-Medula application during the two-month follow-up period with a median number of visits to the application of 143 (range 6-477). A total of 2067 self-monitoring records were made, and 205 text messages were received, most of them related to symptoms description (47%) and doubts about medication (21%). In 3.4% of the cases drug dose adjustments were performed by the pharmacist because of dosing errors or interactions. At the end of the study, a 6-question Likert-type questionnaire for patients and a 22-question test for healthcare professionals showed a high degree of satisfaction (95% and 100% respectively) with the new healthcare pathway. CONCLUSIONS Re-engineering allo-SCT recipients follow-up into an integrated, multidisciplinary model of care facilitated by mHealth tools is feasible and has been associated with a high usability and degree of satisfaction by patients and healthcare professionals. A randomized trial aiming to determine the cost-effectiveness of MY-Medula-based follow-up post-SCT is currently enrolling participants.
Collapse
Affiliation(s)
- S Redondo
- Hematology Department, Hospital de la Santa Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Departamento de Medicina, Universitat Autónoma de Barcelona, Spain.
| | - A De Dios
- Pharmacy Department, Hospital de la Santa Creu i Sant Pau.; Digital Health Department, Hospital de la Santa Creu i Sant Pau
| | - M Gomis-Pastor
- Pharmacy Department, Hospital de la Santa Creu i Sant Pau.; Digital Health Department, Hospital de la Santa Creu i Sant Pau
| | - A Esquirol
- Hematology Department, Hospital de la Santa Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Departamento de Medicina, Universitat Autónoma de Barcelona, Spain
| | - O Aso
- Hematology Nursing Department, Hospital de la Santa Creu i Sant Pau
| | - M Triquell
- Hematology Nursing Department, Hospital de la Santa Creu i Sant Pau
| | - M E Moreno
- Pharmacy Department, Hospital de la Santa Creu i Sant Pau
| | - M Riba
- Pharmacy Department, Hospital de la Santa Creu i Sant Pau
| | - J Ruiz
- Nutrition and Dietetics Department, Hospital de la Santa Creu i Sant Pau
| | - A Blasco
- Nutrition and Dietetics Department, Hospital de la Santa Creu i Sant Pau
| | - E Tobajas
- Psycho-Oncology Department, Hospital de la Santa Creu i Sant Pau
| | - I González
- Hematology Nursing Department, Hospital de la Santa Creu i Sant Pau
| | - J Sierra
- Hematology Department, Hospital de la Santa Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Departamento de Medicina, Universitat Autónoma de Barcelona, Spain
| | - R Martino
- Hematology Department, Hospital de la Santa Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Departamento de Medicina, Universitat Autónoma de Barcelona, Spain
| | - I García-Cadenas
- Hematology Department, Hospital de la Santa Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Departamento de Medicina, Universitat Autónoma de Barcelona, Spain
| |
Collapse
|
7
|
Sánchez-Bayona R, Alva M, López de sa A, Gilarranz YJ, Sánchez de torre A, Tolosa P, de luna A, López-Tarruella S, Lema L, Moreno F, Echavarria I, Madariaga A, Benítez J, Herrero B, Rey M, Ortega J, Gámez S, Modrego A, Lozano RM, Figuero-Pérez L, Jiménez R, Sevilla MG, González I, Beranek MB, de toro M, Massarrah T, del Monte-Millán M, Pinardo M, Manso L, Bueno-Muiño C, García-Sáenz JÁ, Martín M, Ciruelos E. Abstract P3-01-04: A real-world evidence study of everolimus plus endocrine therapy beyond CDK4/6 inhibitors for HR+/HER2- advanced breast cancer. Cancer Res 2023. [DOI: 10.1158/1538-7445.sabcs22-p3-01-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
Abstract
Abstract
Introduction Since the approval a decade ago of everolimus in combination with endocrine therapy (ET), the treatment landscape of metastatic breast cancer (mBC) has changed dramatically. Endocrine monotherapy after progression to CDK4/6 inhibitors has shown a limited progression-free survival (PFS) below 3 months. Evidence of the efficacy of everolimus plus ET after CDK4/6 inhibitors is scarce. Methods We performed a retrospective observational study of patients with mBC treated with everolimus between September 2011 and April 2022 in 4 Spanish hospitals. Clinical and demographic data were collected from medical records. Our main objective was to estimate the median progression-free survival (mPFS) for everolimus + ET in patients previously treated with a CDK4/6 inhibitor. We also collected the adverse events (AE) related to everolimus. Quantitative variables were summarized with medians (range), and qualitative variables with proportions. We used the Kaplan-Meier method for survival estimates. Results We identified a total of 297 mBC patients treated with everolimus plus ET. The median follow-up time was 20 months (interquartile range: 1 – 97 months). In this cohort, the median age at diagnosis was 49 years (26 – 84 years). At the moment of starting everolimus, the median number of previous lines of treatment was 2 (0 – 12), 22% of patients were ‘de novo’ metastatic, 67% presented visceral involvement, 40% had received previous chemotherapy for advanced disease, and 51% (n=152) had received a previous CDK4/6 inhibitor. The ET combined with everolimus was exemestane (77%), fulvestrant (18%), and tamoxifen (5%). 45% of patients were alive at data cut-off. In patients previously treated with a CDK4/6 inhibitor, the estimated median PFS (mPFS) was 5.9 months (95%CI: 5.0 – 7.8 months). In patients without visceral involvement (n=52), mPFS was 7.2 months (95%CI: 5.5 – 11.0 months), and 5.6 months (95%CI: 3.9 – 7.8 months) in the presence of visceral metastasis (n=100). In patients without previous chemotherapy in the metastatic setting (n=109), mPFS was 7.2 months (95%CI: 5.9 – 8.4 months), and 4.6 months (95%CI: 3.1 – 5.7 months) for patients who had received previous chemotherapy (n=43). For patients without a previous CDK4/6 inhibitor (n=145), the median PFS was 8.3 months (95%CI: 6.4 – 10.3 months). Everolimus starting doses were 10 mg (83%), 5 mg (15%), and 7.5 mg (2%). Dexamethasone mouthwash was used by 44% of patients. The most frequent AE were mucositis (51%; 3% grade 3), anemia (41%; 3% grade 3), hyperglycemia (34%; 2% grade 3), rash (28%; 2% grade 3), neumonitis (21%; 2% grade 3), and diarrhea (17%; 1% grade 3). There were no grade 4-5 adverse events. Dose reduction was made in 35% of patients, and in 16% of patients the treatment was discontinued due to toxicity. Conclusions In our cohort, the use of everolimus plus ET in mBC patients previously treated with a CDK4/6 inhibitor showed a clinically significant benefit in terms of PFS, especially in patients without visceral metastasis, and no previous chemotherapy for advanced disease. In this real-world study, the toxicity profile of everolimus was manageable.
Citation Format: Rodrigo Sánchez-Bayona, Manuel Alva, Alfonso López de sa, Yolanda Jerez Gilarranz, Ana Sánchez de torre, Pablo Tolosa, Alicia de luna, Sara López-Tarruella, Laura Lema, Fernando Moreno, Isabel Echavarria, Ainhoa Madariaga, Javier Benítez, Blanca Herrero, Macarena Rey, Justo Ortega, Salvador Gámez, Andrea Modrego, Rocío Martín Lozano, Luis Figuero-Pérez, Roberto Jiménez, Marta González Sevilla, Irene González, Marianela Bringas Beranek, María de toro, Tatiana Massarrah, María del Monte-Millán, Marina Pinardo, Luis Manso, Coralia Bueno-Muiño, José Ángel García-Sáenz, Miguel Martín, Eva Ciruelos. A real-world evidence study of everolimus plus endocrine therapy beyond CDK4/6 inhibitors for HR+/HER2- advanced breast cancer. [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P3-01-04.
Collapse
Affiliation(s)
- Rodrigo Sánchez-Bayona
- 1Medical Oncology Department, Hospital 12 de Octubre, Madrid. SOLTI Cancer Research Group, Barcelona, Spain
| | - Manuel Alva
- 2Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain
| | | | | | | | - Pablo Tolosa
- 6SOLTI Cancer Research Group, Barcelona, Spain/Medical Oncology Department, Hospital 12 de Octubre, Madrid, Madrid, Spain
| | | | - Sara López-Tarruella
- 8Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid, Spain
| | - Laura Lema
- 9Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain
| | | | - Isabel Echavarria
- 11Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio M2arañón, CiberOnc, Madrid, Spain
| | | | | | - Blanca Herrero
- 14Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
| | | | | | - Salvador Gámez
- 17Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
| | | | - Rocío Martín Lozano
- 19Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid
| | - Luis Figuero-Pérez
- 20Medical Oncology Department, Complejo Asistencial Universitario de Salamanca, Castilla y Leon, Spain
| | - Roberto Jiménez
- 21Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | | | - Irene González
- 23Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | | | - María de toro
- 25Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Tatiana Massarrah
- 26Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid, Spain
| | - María del Monte-Millán
- 27Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid, Spain
| | - Marina Pinardo
- 28Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Luis Manso
- 29Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Coralia Bueno-Muiño
- 30Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, 28009 Madrid, spail, Spain
| | | | - Miguel Martín
- 32Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Eva Ciruelos
- 33SOLTI Breast Cancer Research Group, Barcelona, Spain/Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain
| |
Collapse
|
8
|
Alvero-Cruz JR, Alarcón-Martín E, García-Romero J, Ruiz-Galdon M, Carrillo-Albornoz-Gil M, Polvillo R, González I, Reyes-Engel A, Royo JL. Moderate exercise reveals the influence of ACTN3 R577X and ACE I/D polymorphisms on physical performance in non-athlete active subjects. Gene 2023; 850:146958. [DOI: 10.1016/j.gene.2022.146958] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Revised: 09/13/2022] [Accepted: 10/04/2022] [Indexed: 11/06/2022]
|
9
|
Roa F, González I, Savic D, Van Goubergen J, Santer F, Puhr M, Toledo J, Skvortsova I, Culig Z, Klocker H. Role of mitochondrial dynamics in tumorigenic potential and docetaxel resistance in prostate cancer. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01948-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
10
|
González I, Moyano M, Lobato RM, Trujillo HM. Analysis of the radicalization of the 17-A terrorist cell: an empirical approach using the 3N model ( Análisis del proceso de radicalización de la célula terrorista del 17-A: una aproximación empírica desde el modelo 3N). International Journal of Social Psychology 2022. [DOI: 10.1080/02134748.2022.2096259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
11
|
Tarragó D, González I, González-Escribano MF. HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection. BMC Genomics 2022; 23:455. [PMID: 35725386 PMCID: PMC9208114 DOI: 10.1186/s12864-022-08689-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Accepted: 06/10/2022] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Congenital cytomegalovirus immunopathogenesis is largely unknown and multifactorial due to the complex interactions between viral, maternal, placental, and child factors. Polymorphisms in the HLA-E binding UL4015-23 peptide mimics HLA-E complexed peptides from certain HLA-A, -B, -C and -G alleles, which regulate the cellular immune response driven by natural killer-cells (NK) and CD8 + T cells. The aim of this study was to compare UL4015-23 peptides distribution in congenital CMV and the counterpart HLA Class I peptides in a healthy cohort to investigate risk factors and markers for cCMV disease. In this 10-year retrospective study, the UL40 gene was directly sequenced from 242 clinical samples from 199 cases of congenital CMV (166 children and 33 pregnant or breast feeding women). Distribution of HLA-E binding UL4015-23 peptides was analyzed and compared to those of HLA Class I observed in a cohort of 444 healthy individuals. RESULTS Nineteen different HLA-E binding UL4015-23 peptides were found. Three of them (VMAPRTLIL, VMAPRTLLL, VMAPRTLVL) were found in 88.3% of UL40 and 100% of HLA Class I of healthy individuals. In contrast, 15 of them (10.7%) were not found in HLA Class I. The VMAPRTLFL peptide was found in 1% of UL40 and all HLA-G alleles. Significant differences in peptide (VMAPRTLIL, VMAPRTLLL, VMAPRTLVL, other UL4015-23 peptides, other HLA Class I peptides) distribution between UL4015-23 from congenital CMV and HLA-A, -B, -C and -G from healthy individuals were found. CONCLUSIONS Our findings suggest that a mismatch between UL4015-23 peptides and HLA Class I peptides between children and mothers might play a role in congenital CMV disease, and it may account for differences in outcome, morbidity and sequelae.
Collapse
Affiliation(s)
- David Tarragó
- National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda- Pozuelo km 2, 28220 Majadahonda, Madrid, Spain.
- CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
| | - Irene González
- National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda- Pozuelo km 2, 28220 Majadahonda, Madrid, Spain
| | | |
Collapse
|
12
|
Norman FF, Chamorro S, Braojos F, López-Miranda E, Chamorro J, González I, Martín O, Pérez-Molina JA. Strongyloides in bronchoalveolar lavage fluid: practical implications in the COVID-19 era. J Travel Med 2022; 29:6325577. [PMID: 34297094 PMCID: PMC8344744 DOI: 10.1093/jtm/taab114] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2021] [Revised: 07/15/2021] [Accepted: 07/16/2021] [Indexed: 02/07/2023]
Abstract
Latent infections caused by Strongyloides sp. may become symptomatic years after initial exposure in endemic areas especially in specific contexts such as following administration of corticosteroids (for COVID-19 or other diseases). Heightened awareness of these reactivations and timely diagnosis may be critical to prevent complications and improve outcome.
Collapse
Affiliation(s)
| | - Sandra Chamorro
- National Referral Unit for Tropical Diseases, Infectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain
| | - Francisco Braojos
- National Referral Unit for Tropical Diseases, Infectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain
| | | | - Jesús Chamorro
- Oncology Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain
| | - Irene González
- Pathology Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain
| | - Oihane Martín
- Microbiology Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain
| | - José-Antonio Pérez-Molina
- National Referral Unit for Tropical Diseases, Infectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain
| |
Collapse
|
13
|
González I, Moyano M, Lobato RM, Trujillo HM. Evidence of Psychological Manipulation in the Process of Violent Radicalization: An Investigation of the 17-A Cell. Front Psychiatry 2022; 13:789051. [PMID: 35280161 PMCID: PMC8905186 DOI: 10.3389/fpsyt.2022.789051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/04/2021] [Accepted: 01/21/2022] [Indexed: 11/14/2022] Open
Abstract
INTRODUCTION Radicalization leading to violence is a complex social process that frequently targets young people. In this study, we examine the 17-A cell, which carried out terrorist attacks in the Spanish cities of Barcelona and Cambrils on August 17, 2017. We focus on the psychological manipulation techniques used to radicalized members of the cell. METHODS Using deductive content analysis, we examined the judicial order of the National High Court related to "Operation Ramblas" and the police proceedings of Cuerpo de Mossos d'Esquadra (CME) associated with the Barcelona and Cambrils attacks. Our goal was to determine whether psychological manipulation was used on the cell members and, if so, how frequently. RESULTS Our results suggest that different psychological manipulation techniques were used on the 17-A cell members to facilitate their use of ideological violence. The most frequent strategies were cognitive control (control of attention, group identification, and denigration of critical thinking), environmental control (control of information), and emotional control (authoritarian leadership). CONCLUSIONS This study provides evidence that psychological manipulation techniques were used in the radicalization of 17-A cell members. The results are discussed in the context of previous research on the psychology of violent extremism and terrorism. We highlight the need for prevention and psychosocial interventions to steer young people away from violent extremism.
Collapse
Affiliation(s)
- Irene González
- Department of Psychology, University of Cordoba, Cordoba, Spain
| | - Manuel Moyano
- Department of Psychology, University of Cordoba, Cordoba, Spain
| | - Roberto M Lobato
- Department of Psychology, Marbella International University Centre, Marbella, Spain
| | - Humberto M Trujillo
- Department of Methodology for Behavioral Sciences, University of Granada, Granada, Spain
| |
Collapse
|
14
|
Fernández O, Aladro Y, Arroyo R, Brieva L, Calles-Hernández MC, Carrascal P, Comabella M, Costa-Frossard L, Eichau S, García-Merino JA, Ginestal R, González I, Izquierdo G, Martínez-Ginés ML, Meca-Lallana JE, Mendibe-Bilbao MM, Oterino A, Prieto JM, Río J, Ramió-Torrentà L, Romero-Pinel L, Téllez N, Rodríguez-Antigüedad A. [12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)]. Rev Neurol 2021; 70:379-390. [PMID: 32390131 DOI: 10.33588/rn.7010.2020121] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Like every year, after the ECTRIMS Congress, renowned Spanish neurologists who are experts in multiple sclerosis presented the main novelties in research in this field at the Post-ECTRIMS Meeting. AIM To summarise the content presented at the 12th edition of the Post-ECTRIMS Meeting, which took place in September 2019 in Sevilla and is presented in two parts. DEVELOPMENT This first part addresses the latest studies on vitamin D deficiency and the discrepancies that currently exist regarding its treatment. The advances made in epigenetics allow us to present this approach as a possible biomarker of multiple sclerosis. An account is provided to explain the growing importance of imaging techniques to detect atrophy and other phenomena that occur during the disease, such as changes in iron concentration or remyelination processes, which allow us to further our understanding of the mechanisms of cortical pathology, and the dimensionality of neurodegeneration during its course. Findings related to immunological mechanisms and advances in potential antigen-specific therapies are discussed. The contribution presents the latest studies on the assessment of cognitive impairment and its rehabilitation, which are becoming increasingly important due to the high prevalence of these disorders and the absence of their systematic assessment in clinical practice. Finally, the unmet social and health needs of multiple sclerosis patients in our country are presented, with emphasis on the current deficits in the system of social protection.
Collapse
Affiliation(s)
- O Fernández
- Instituto de Investigación Biomédica de Málaga. IBIMA, Málaga, España
| | - Y Aladro
- Hospital Universitario de Getafe, 28905 Getafe, España
| | - R Arroyo
- Hospital Quirón, Pozuelo de Alarcón, España
| | - Ll Brieva
- Hospital Arnau de Vilanova, 25198 Lleida, España
| | | | | | - M Comabella
- Hospitals Vall d'Hebron, 08035 Barcelona, España
| | | | - S Eichau
- Hospital Universitario Virgen Macarena, 41003 Sevilla, España
| | - J A García-Merino
- Hospital Universitario Puerta de Hierro-Majadahonda, 28035 Majadahonda, España
| | - R Ginestal
- Fundación Jiménez Díaz, 28040 Madrid, España
| | | | | | | | | | | | - A Oterino
- Hospital Universitario Marqués de Valdecilla, Santander, España
| | - J M Prieto
- Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, España
| | - J Río
- Hospitals Vall d'Hebron, 08035 Barcelona, España
| | | | - L Romero-Pinel
- Hospital General Universitari de Bellvitge, 08907 Hospitalet de Ll., España
| | - N Téllez
- Hospital Clínico Universitario, 47005 Valladolid, España
| | | |
Collapse
|
15
|
Torales J, Ventriglio A, González I, Castaldelli-Maia J. Kleptomania as a neglected disorder in psychiatry. Eur Psychiatry 2021. [PMCID: PMC9471801 DOI: 10.1192/j.eurpsy.2021.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Kleptomania is an impulse control disorder characterized by the irresistible urge to steal not for monetary gain. Since its conceptualization, this categorical diagnosis has been conflated with common beliefs regarding the social class and gender such as the idea that women are intrinsically fragile and that people in the middle class were unlikely to commit theft. Also, its use has been controversial in the medical and forensic fields. This presentation will provide a historical excursus through the definitions of the syndrome and summarize the available pharmacological and psychotherapeutic options for its treatment. Currently, there is a lack of systematic studies regarding the clinical characteristics of kleptomania and its treatment options for practical standardized approaches.
Collapse
|
16
|
Taboada M, Baluja A, Santos LD, González I, Veiras S, Caruezo V, Naveira A, Mirón P, Novoa C, Doldán P, Calvo A, Tubio A, Selas S, Eiras M, Martínez A, Campaña O, Rodríguez MT, Diaz-Vieito M, Cariñena A, Otero P, Mariño G, Domínguez M, Muniategui I, Aneiros F, Alvarez J. Effectiveness of dexmedetomidine combined with high flow nasal oxygen and long periods of awake prone positioning in moderate or severe COVID-19 pneumonia. J Clin Anesth 2021; 72:110261. [PMID: 33839432 PMCID: PMC8011721 DOI: 10.1016/j.jclinane.2021.110261] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Revised: 03/10/2021] [Accepted: 03/12/2021] [Indexed: 12/28/2022]
Affiliation(s)
- Manuel Taboada
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain.
| | - Aurora Baluja
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Laura Dos Santos
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Irene González
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Sonia Veiras
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Valentín Caruezo
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Alberto Naveira
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Paula Mirón
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Carmen Novoa
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Patricia Doldán
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Andrea Calvo
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Ana Tubio
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Salomé Selas
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - María Eiras
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Adrián Martínez
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Olga Campaña
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - María Teresa Rodríguez
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - María Diaz-Vieito
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Agustín Cariñena
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Pablo Otero
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Gumersindo Mariño
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - María Domínguez
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Ignacio Muniategui
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Francisco Aneiros
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| | - Julián Alvarez
- Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago. Spain
| |
Collapse
|
17
|
Taboada M, González M, Álvarez A, González I, García J, Eiras M, Vieito MD, Naveira A, Otero P, Campaña O, Muniategui I, Tubio A, Costa J, Selas S, Cariñena A, Martínez A, Veiras S, Aneiros F, Caruezo V, Baluja A, Alvarez J. Effectiveness of Prone Positioning in Nonintubated Intensive Care Unit Patients With Moderate to Severe Acute Respiratory Distress Syndrome by Coronavirus Disease 2019. Anesth Analg 2021; 132:25-30. [PMID: 32947292 PMCID: PMC7523477 DOI: 10.1213/ane.0000000000005239] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
BACKGROUND In the treatment for severe acute respiratory distress syndrome (ARDS) from coronavirus disease 2019 (COVID-19), the World Health Organization (WHO) recommends prone positioning (PP) during mechanical ventilation for periods of 12-16 h/d to potentially improve oxygenation and survival. In this prospective observational study, we evaluated the ability of long PP sessions to improve oxygenation in awake intensive care unit (ICU) patients with moderate or severe ARDS due to COVID-19. METHODS The study was approved by the ethics committee of Galicia (code No. 2020-188), and all patients provided informed consent. In this case series, awake patients with moderate or severe ARDS by COVID-19 admitted to the ICU at University Hospital of Santiago from March 21 to April 5, 2020 were prospectively analyzed. Patients were instructed to remain in PP as long as possible until the patient felt too tired to maintain that position. Light sedation was administered with dexmedetomidine. The following information was collected: number and duration of PP sessions; tissue O2 saturation (StO2) and blood gases before, during, and following a PP session; need of mechanical ventilation; duration of ICU admission; and ICU outcome. Linear mixed-effects models (LMM) were fit to estimate changes from baseline with a random effect for patient. RESULTS Seven patients with moderate or severe ARDS by COVID-19 were included. All patients received at least 1 PP session. A total of 16 PP sessions were performed in the 7 patients during the period study. The median duration of PP sessions was 10 hours. Dexmedetomidine was used in all PP sessions. Oxygenation increased in all 16 sessions performed in the 7 patients. The ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FIO2) significantly increased during PP (change from baseline 110 with 97.5% confidence interval [CI], 19-202) and, after PP, albeit not significantly (change from baseline 38 with 97.5% CI, -9.2 to 85) compared with previous supine position. Similarly, tissue oxygenation underwent a small improvement during PP (change from baseline 2.6% with 97.5% CI, 0.69-4.6) without significant changes after PP. Two patients required intubation. All patients were discharged from the ICU. CONCLUSIONS We found that PP improved oxygenation in ICU patients with COVID-19 and moderate or severe ARDS. PP was relatively well tolerated in our patients and may be a simple strategy to improve oxygenation trying to reduce the number of patients in mechanical ventilation and the length of stay in the ICU, especially in COVID-19 pandemic.
Collapse
Affiliation(s)
- Manuel Taboada
- From the Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago, Santiago, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
López-Pintor E, Grau J, González I, Bernal-Soriano MC, Quesada JA, Lumbreras B. Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies. Respir Med 2020; 176:106280. [PMID: 33302143 DOI: 10.1016/j.rmed.2020.106280] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Accepted: 11/30/2020] [Indexed: 12/27/2022]
Abstract
BACKGROUND Patient adherence to treatment in chronic obstructive pulmonary disease (COPD) is essential to optimize disease management. We aimed to assess the impact of patients' perception of their treatment and disease on adherence and Health-Related Quality of Life (HRQL) in patients attending a community pharmacy, where usually subjects have a better condition than those in clinical settings. METHODS We performed a cross-sectional study of 318 patients with COPD in treatment with inhalers in the last 3 months from 53 community pharmacies. We assessed HRQL with St George's Respiratory Questionnaire (SGRQ). Persistence was assessed from the three previous refills and adherence through the Test of Adherence to Inhalers test. RESULTS Persistence was achieved by 78.6% of the patients and 58.5% had good adherence. Patients having a multidose DPI and those with MDI showed a 2.8-fold and 4.1-fold increased association, respectively, with intermediate/poor adherence in comparison with those having a single dose DPI. Those patients who did not have knowledge about COPD (aOR 2.106, p = 0.006) and those who thought that the inhaler effectiveness was fair/poor (aOR 2.361, p = 0.006) were more likely to have intermediate/poor adherence. Overall SGRQ score was significantly worse in patients with intermediate/poor adherence (p = 0.036) and in those who thought the inhaler's effectiveness was fair/poor (p < 0.001). CONCLUSIONS The type of inhaler and patients' knowledge and perceptions of their disease and treatment were associated with good adherence and higher HRQL. Clinicians should promote shared-decision making in the choice of inhaler depending on patients' individual abilities and beliefs.
Collapse
Affiliation(s)
- E López-Pintor
- Department of Engineering, Area of Pharmacy and Pharmaceutical Technologies, Miguel Hernandez University, San Juan de Alicante, Alicante, Spain.
| | - J Grau
- Pneumology Department, General Hospital of Elche, Alicante, Spain.
| | - I González
- Community Pharmacist in Alicante, Spain, Spanish Society of Community Pharmacy, SEFAC, Spain.
| | - M C Bernal-Soriano
- Department of Public Health, History of Science and Gynecology, Miguel Hernández University and CIBER en Epidemiología y Salud Pública, Crtra Alicante-Valencia km 81, Sant Joan d'Alacant, 03550, Alicante, Spain.
| | - J A Quesada
- Department of Clinical Medicine. Miguel Hernandez University, San Juan de Alicante, Alicante, Spain.
| | - B Lumbreras
- Department of Public Health, History of Science and Gynecology, Miguel Hernández University and CIBER en Epidemiología y Salud Pública, Crtra Alicante-Valencia km 81, Sant Joan d'Alacant, 03550, Alicante, Spain.
| |
Collapse
|
19
|
Gómez-Flores P, Velasco-Alvarez N, González I, Sánchez-Vázquez V. Biotechnological processes improved with electric fields: the importance of operational parameters selection. RMIQ 2020. [DOI: 10.24275/rmiq/bio1689] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
20
|
Fernández O, Aladro Y, Arroyo R, Brieva L, Calles-Hernández MC, Carrascal P, Comabella M, Costa-Frossard L, Eichau S, García-Merino JA, Ginestal R, González I, Izquierdo G, Martínez-Ginés ML, Meca-Lallana JE, Mendibe-Bilbao MM, Oterino A, Prieto JM, Río J, Ramió-Torrentà L, Romero-Pinel L, Téllez N, Rodríguez-Antigüedad A. 12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (II). Rev Neurol 2020; 70:417-429. [PMID: 32436209 DOI: 10.33588/rn.7011.2020122] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Like every year, after the ECTRIMS Congress, renowned Spanish neurologists who are experts in multiple sclerosis presented the main novelties in research in this field at the Post-ECTRIMS Meeting. AIM To summarise the content presented at the 12th edition of the Post-ECTRIMS Meeting, which took place in September 2019 in Sevilla and is presented in two parts. DEVELOPMENT In this second part, the most recent evidence on the use of disease-modifying treatments during pregnancy is presented. Details are provided concerning the results of phase 3 clinical trials conducted to evaluate the efficacy and safety of two potential disease-modifying treatments for relapsing-remitting multiple sclerosis: ponesimod and ofatumumab. For the progressive forms, both available disease modifying treatments and others still in the research phase are reviewed. In the field of stem cell therapies, the article includes the results of the only clinical trial carried out to date comparing patients with relapsing-remitting multiple sclerosis treated with autologous haematopoietic stem cell transplantation and those treated with disease-modifying therapies. There are no important developments as regards symptomatic treatments, although the European Academy of Neurology has published a guide on palliative care. The various sources of information that collect pharmacovigilance data in the post-marketing setting are reviewed. CONCLUSIONS Patients diagnosed in recent years tend to have less severe multiple sclerosis, probably due to the fact that it is diagnosed in its milder stages together with the steady increase in the number of treatments available.
Collapse
Affiliation(s)
- O Fernández
- Instituto de Investigación Biomédica de Málaga. IBIMA, Málaga, España
| | - Y Aladro
- Hospital Universitario de Getafe, 28905 Getafe, España
| | - R Arroyo
- Hospital Quirón, Pozuelo de Alarcón, España
| | - Ll Brieva
- Hospital Arnau de Vilanova, 25198 Lleida, España
| | | | | | - M Comabella
- Hospitals Vall d'Hebron, 08035 Barcelona, España
| | | | - S Eichau
- Hospital Universitario Virgen Macarena, 41003 Sevilla, España
| | - J A García-Merino
- Hospital Universitario Puerta de Hierro-Majadahonda, 28035 Majadahonda, España
| | - R Ginestal
- Fundación Jiménez Díaz, 28040 Madrid, España
| | | | | | | | | | | | - A Oterino
- Hospital Universitario Marqués de Valdecilla, Santander, España
| | - J M Prieto
- Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, España
| | - J Río
- Hospitals Vall d'Hebron, 08035 Barcelona, España
| | | | - L Romero-Pinel
- Hospital General Universitari de Bellvitge, 08907 Hospitalet de Ll., España
| | - N Téllez
- Hospital Clínico Universitario, 47005 Valladolid, España
| | | |
Collapse
|
21
|
Báez-Díaz C, Blanco-Blázquez V, Sánchez-Margallo FM, Bayes-Genis A, González I, Abad A, Steendam R, Franssen O, Palacios I, Sánchez B, Gálvez-Montón C, Crisóstomo V. Microencapsulated Insulin-Like Growth Factor-1 therapy improves cardiac function and reduces fibrosis in a porcine acute myocardial infarction model. Sci Rep 2020; 10:7166. [PMID: 32346015 PMCID: PMC7188803 DOI: 10.1038/s41598-020-64097-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2019] [Accepted: 04/03/2020] [Indexed: 12/12/2022] Open
Abstract
Insulin-like growth factor-1 (IGF-1) has demonstrated beneficial effects after myocardial infarction (MI). Microencapsulation of IGF-1 could potentially improve results. We aimed to test the effect of an intracoronary (IC) infusion of microencapsulated IGF-1 in a swine acute MI model. For that purpose IC injection of a 10 ml solution of 5 × 106 IGF-1 loaded microspheres (MSPs) (n = 8, IGF-1 MSPs), 5 × 106 unloaded MSPs (n = 9; MSPs) or saline (n = 7; CON) was performed 48 hours post-MI. Left ventricular ejection fraction (LVEF), indexed ventricular volumes and infarct size (IS) were determined by cardiac magnetic resonance at pre-injection and 10 weeks. Animals were euthanized at 10 weeks, and myocardial fibrosis and vascular density were analysed. End-study LVEF was significantly greater in IGF-1 MSPs compared to MSPs and CON, while ventricular volumes exhibited no significant differences between groups. IS decreased over time in all groups. Collagen volume fraction on the infarct area was significantly reduced in IGF-1 MSPs compared to CON and MSPs. Vascular density analysis of infarct and border zones showed no significant differences between groups. In conclusion, the IC injection of 5 × 106 IGF-1 loaded MSPs in a porcine acute MI model successfully improves cardiac function and limits myocardial fibrosis, which could be clinically relevant.
Collapse
Affiliation(s)
- Claudia Báez-Díaz
- Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.
- CIBERCV, Madrid, Spain.
| | | | | | - Antoni Bayes-Genis
- CIBERCV, Madrid, Spain
- ICREC (Heart Failure and Cardiac Regeneration) Research Programme, Health Sciences Research Institute Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain
| | - Irene González
- Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain
| | - Ana Abad
- Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain
| | - Rob Steendam
- Innocore Pharmaceuticals, Groningen, The Netherlands
| | | | | | | | - Carolina Gálvez-Montón
- CIBERCV, Madrid, Spain
- ICREC (Heart Failure and Cardiac Regeneration) Research Programme, Health Sciences Research Institute Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain
| | - Verónica Crisóstomo
- Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain
- CIBERCV, Madrid, Spain
| |
Collapse
|
22
|
Martínez-Cruz MA, Yañez-Aulestia A, Ramos-Sánchez G, Oliver-Tolentino M, Vera M, Pfeiffer H, Ramírez-Rosales D, González I. Unraveling the effects on lithium-ion cathode performance by cation doping M-Li 2CuO 2 solid solution samples (M = Mn, Fe and Ni). Dalton Trans 2020; 49:4549-4558. [PMID: 32196043 DOI: 10.1039/d0dt00273a] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Cation doping is one of the most dynamic strategies to enhance the electrochemical properties of cathode materials for lithium-ion batteries. Nevertheless, the maximum partial substitution capacity depends on the solubility of each metal ion, and so the formation of impurities is a very common consequence. Thus, the correlation between electrochemical performance and the doping effect is frequently unknown. In this study, the effect of the partial substitution of copper by manganese, iron or nickel in Li2CuO2 is evaluated, as well as the effect on the electrochemical performance of the modified Li2CuO2 samples as lithium ion battery cathode materials. XRD characterization confirmed single phase formation for all samples, and the incorporation of the transition metal in the Li2CuO2 structure was evaluated by XRD profile fitting, EPR and 7Li-NMR. The results showed modifications in intra- and inter-chain interactions, associated with the variations in the Cu-O-Cu bond angle and changes in magnetic order, due to the presence of the doping transition metal. Among all samples, only manganese partial substitution reveals a drastic improvement in the electrochemical stability during the charge/discharge processes even at potentials higher than 3.9 V. It was corroborated that the higher stability is attributed to (i) the increase in the superexchange interactions between the copper sites and manganese, directly modifying lithium diffusivity and electronic conductivity, both inferred from dynamic thermogravimetric analysis for CO2 sorption and conductivity tests, respectively and (ii) the lower propensity to enable O2 evolution during several charge cycles. These results are totally attributed to manganese cation partial substitution, which has a huge impact on the utilization of copper-based materials in real applications.
Collapse
Affiliation(s)
- M A Martínez-Cruz
- Universidad Autónoma Metropolitana-Iztapalapa, Departamento de Química, 09340, Ciudad de México, Mexico
| | - A Yañez-Aulestia
- Laboratorio de Fisicoquímica y Reactividad de Superficies (LaFReS), Instituto de Investigaciones en Materiales, Universidad Nacional Autónoma de México, Ciudad Universitaria, Circuito exterior s/n, 04510, Del. Coyoacán, Ciudad de México, Mexico.
| | - G Ramos-Sánchez
- CONACYT - Universidad Autónoma Metropolitana - Iztapalapa, 09340, Ciudad de México, Mexico.
| | - M Oliver-Tolentino
- CONACYT - Universidad Autónoma Metropolitana - Iztapalapa, 09340, Ciudad de México, Mexico.
| | - M Vera
- Universidad Autónoma Metropolitana-Iztapalapa, Departamento de Química, 09340, Ciudad de México, Mexico
| | - H Pfeiffer
- Laboratorio de Fisicoquímica y Reactividad de Superficies (LaFReS), Instituto de Investigaciones en Materiales, Universidad Nacional Autónoma de México, Ciudad Universitaria, Circuito exterior s/n, 04510, Del. Coyoacán, Ciudad de México, Mexico.
| | - D Ramírez-Rosales
- Instituto Politecnico Nacional-ESFM, Av. IPN S/N, Edif. 9 U.P. Zacatenco, Col. San Pedro Zacatenco, México City 07738, Mexico
| | - I González
- Universidad Autónoma Metropolitana-Iztapalapa, Departamento de Química, 09340, Ciudad de México, Mexico
| |
Collapse
|
23
|
González I, Calvino M, Trejo A, Salazar F, Cruz-Irisson M. Confinement effect on the low temperature specific heat for ultrathin silicon nanowires: a first principles study. J Phys Condens Matter 2019; 31:425303. [PMID: 31252420 DOI: 10.1088/1361-648x/ab2dd4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
This work studied the phonon confinement effects at the low temperature specific heat of Si nanowires from first principles using density functional perturbation theory. The nanowires were modeled in the [0 0 1] direction for three different diameters, with the largest cross section being approximately 10 Å. The results indicate the specific heat can be described at low temperatures using a third-grade polynomial of the form c v = λT + βT 2 + γT3, where the coefficients of quadratic and cubic terms are almost nonexistent for small diameters. These terms begin to have relevance at larger diameters. Further analysis shows λ > β > γ, which shows the phonon confinement (λ) and surface atoms (β) become more important than the volumetric contribution (γ) for ultrathin nanowires at low temperatures.
Collapse
Affiliation(s)
- I González
- Instituto Politécnico Nacional, ESIME-Culhuacan, Ciudad de México, Mexico
| | | | | | | | | |
Collapse
|
24
|
Robledo-Mahón T, Martín MA, Gutiérrez MC, Toledo M, González I, Aranda E, Chica AF, Calvo C. Sewage sludge composting under semi-permeable film at full-scale: Evaluation of odour emissions and relationships between microbiological activities and physico-chemical variables. Environ Res 2019; 177:108624. [PMID: 31422221 DOI: 10.1016/j.envres.2019.108624] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/07/2019] [Revised: 07/12/2019] [Accepted: 08/02/2019] [Indexed: 06/10/2023]
Abstract
In the present study, physico-chemical characteristics, heavy metals content, odour emissions, microbial enumeration and enzymatic activities were analysed during industrial scale composting of sewage sludge partially pre-treated to evaluate the effect of a combined system of semi-permeable film and aeration on these parameters. The results related to physico-chemical parameters showed a decrease in total organic carbon (TOC), organic matter (OM), total carbon (TC) along the process. Volatile solids (VS) were also reduced, reaching 36% at 120 days, which is above the limit according to the current legislation. Similarly, metal content was found to be an important variable in the evolution of enzymatic activity, while lead (Pb), zinc (Zn), and nickel (Ni) were the most influential. Moreover, heavy metals were found below the limit of type B compost quality or European class 2 at the end of the process, which is suitable for agriculture soil. The odorous impact generated during the hydrolytic stage was reduced to an average value of 4 ouE/s. This suggests that, covered stage with the semi-permeable film, could be a viable solution to mitigate odour emissions. The highest temperature was reached at 10 days and it was favoured by semi-permeable film. Temperature promoted the presence of thermophilic bacteria and fungi and indicated an early biodegradation process mediated by microorganisms. Statistical analyses revealed a high correlation of physico-chemical variables with microbial activity. Thus, samples from the first 14 days were highly correlated with enzymatic activities such as β-glucosidase (Ac-βGlu), protease (Ac-Pr), and dehydrogenase (Ac-De), which have usually been involved in the hydrolysis of organic matter.
Collapse
Affiliation(s)
- T Robledo-Mahón
- Institute of Water Research, Department of Microbiology. University of Granada. Ramón Cajal nº 4, 18071 Granada, Spain
| | - M A Martín
- University of Cordoba (Spain) - Department of Inorganic Chemistry and Chemical Engineering. Campus Universitario de Rabanales. Carretera N-IV, km 396, Edificio Marie Curie, 14071 Córdoba, Spain.
| | - M C Gutiérrez
- University of Cordoba (Spain) - Department of Inorganic Chemistry and Chemical Engineering. Campus Universitario de Rabanales. Carretera N-IV, km 396, Edificio Marie Curie, 14071 Córdoba, Spain
| | - M Toledo
- University of Cordoba (Spain) - Department of Inorganic Chemistry and Chemical Engineering. Campus Universitario de Rabanales. Carretera N-IV, km 396, Edificio Marie Curie, 14071 Córdoba, Spain
| | - I González
- University of Cordoba (Spain) - Department of Inorganic Chemistry and Chemical Engineering. Campus Universitario de Rabanales. Carretera N-IV, km 396, Edificio Marie Curie, 14071 Córdoba, Spain
| | - E Aranda
- Institute of Water Research, Department of Microbiology. University of Granada. Ramón Cajal nº 4, 18071 Granada, Spain
| | - A F Chica
- University of Cordoba (Spain) - Department of Inorganic Chemistry and Chemical Engineering. Campus Universitario de Rabanales. Carretera N-IV, km 396, Edificio Marie Curie, 14071 Córdoba, Spain
| | - C Calvo
- Institute of Water Research, Department of Microbiology. University of Granada. Ramón Cajal nº 4, 18071 Granada, Spain
| |
Collapse
|
25
|
Santos-Mendoza IO, Vázquez-Arenas J, González I, Ramos-Sánchez G, Castillo-Araiza CO. Revisiting Electrochemical Techniques to Characterize the Solid-State Diffusion Mechanism in Lithium-Ion Batteries. International Journal of Chemical Reactor Engineering 2019. [DOI: 10.1515/ijcre-2018-0095] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
AbstractLithium-ion batteries (LiBs) have gained a worldwide position as energy storage devices due to their high energy density, power density and cycle life. Nevertheless, these performance parameters are yet insufficient for current and future demands diversifying their range of applications, and competitiveness against other power sources. In line with the materials science, the optimization of LiBs, first, requires an in-depth characterization and understanding of their determining steps regarding transport phenomena and electrode kinetics occurring within these devices. Experimental and theoretical studies have identified the solid-state diffusion of Li+into the composite cathode material as one of the transport mechanisms limiting the performance of LiBs, in particular at high charge and discharge rates (C-rates). Nowadays, there is however ambivalence to characterize this mass transport mechanism using the diffusion coefficient calculated either by electrochemical techniques orab initioquantum chemistry methods. This contribution revisits conventional electrochemical methodologies employed in literature to estimate mass transport diffusivity of LiBs, in particular using LiFePO4in the cathode, and their suitability and reliability are comprehensively discussed. These experimental and theoretical methods include Galvanostatic and Potentiostatic Intermittent Titration Technique (GITT and PITT), Electrochemical Impedance Spectroscopy (EIS), Cyclic Voltammetry (CV) andab initioquantum chemistry methods. On the one hand, experimental methods seem not to isolate the diffusion mechanism in the solid phase; thus, obtaining an unreliable apparent diffusion coefficient (ranging from 10–10to 10–16 cm2 s−1), which only serves as a criterion to discard among a set of LiBs. On the other hand, atomistic approaches based onab initio, density functional theory (DFT), cannot yet capture the complexity of the local environments involved at this scale; in consequence, these approaches have predicted inadequate diffusion coefficients for LiFePO4(ranging from 10–6to 10–7 cm2 s−1) which strongly differ from experimental values. This contribution, at long last, remarks the factors influencing diffusion mechanisms and addresses the uncertainties to characterize this transport mechanism in the cathode, stressing the needs to establish methods to determine the diffusion coefficient accurately, coupling electrochemical techniques,ab initiomethods, and engineering approaches based on modeling.
Collapse
|
26
|
Castillo O, González I, Prieto E, Pérez T, Altemir I, Pablo LE, Pueyo V. Effects of prenatal exposure to alcohol, tobacco and other drugs of abuse on retinal development. Arch Soc Esp Oftalmol (Engl Ed) 2019; 94:18-24. [PMID: 30270036 DOI: 10.1016/j.oftal.2018.08.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Revised: 07/31/2018] [Accepted: 08/05/2018] [Indexed: 06/08/2023]
Abstract
PURPOSE To assess structural changes in the retina using optical coherence tomography (OCT) in children prenatally exposed to toxic substances. METHODS The study included a total of 49 infants, aged between 5 and 18years, exposed to toxic substances during pregnancy. Among the exposed children, 25 were exposed to tobacco, 20 were exposed to alcohol, and 4 children were exposed to other drugs of abuse. All children underwent a complete ophthalmology examination, including an OCT. The results were compared against a control group composed of 25 infants, age matched with controlled pregnancy, and not exposed to toxic substances. RESULTS Children prenatally exposed to toxic substances showed significantly thinner average retinal nerve fibre layer (RNFL) compared with control children (81.5 vs. 99.7μm; P<.005), as well as RNFL thinning in its four quadrants (superior RNFL: 97.5 vs. 127.5μm; P<.005; nasal RNFL: 61.5 vs. 72.3μm; P<.005; inferior RNFL: 99.8 vs. 128.6μm; P<.005, temporal RNFL: 58.3 vs. 68.2μm; P<.005). Exposed children also exhibited a thinner ganglion cell layer (72.9 vs. 85.9; P<.005). Greater RNFL thinning was observed in children exposed to drugs of abuse (RNFL thinner average=72), followed by children exposed to alcohol (RNFL thinner average=72.9), and finally the least affected were those children exposed to tobacco during pregnancy (RNFL=94.6). CONCLUSION Toxic substances during pregnancy interfere in retinal development. These results strengthen the evidence about the avoidance of any toxic substance during pregnancy.
Collapse
Affiliation(s)
- O Castillo
- Instituto Investigación Sanitaria Aragón (IIS Aragón), Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, España.
| | - I González
- Instituto Investigación Sanitaria Aragón (IIS Aragón), Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - E Prieto
- Instituto Investigación Sanitaria Aragón (IIS Aragón), Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - T Pérez
- Instituto Investigación Sanitaria Aragón (IIS Aragón), Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - I Altemir
- Instituto Investigación Sanitaria Aragón (IIS Aragón), Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - L E Pablo
- Instituto Investigación Sanitaria Aragón (IIS Aragón), Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - V Pueyo
- Instituto Investigación Sanitaria Aragón (IIS Aragón), Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, España
| |
Collapse
|
27
|
González I, Molina-Ortega A, Pérez-Romero P, Echevarría JE, He L, Tarragó D. Varicella-zoster virus clades circulating in Spain over two decades. J Clin Virol 2018; 110:17-21. [PMID: 30517902 DOI: 10.1016/j.jcv.2018.11.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2018] [Revised: 08/30/2018] [Accepted: 11/26/2018] [Indexed: 11/28/2022]
Abstract
BACKGROUND Despite childhood universal VZV immunization was introduced in 2015, there are no data on VZV clade distribution in Spain. OBJECTIVES To characterize the varicella-zoster virus strains circulating in Spain between 1997 and 2016. STUDY DESIGN In this retrospective study, we determined the VZV clades in 294 patients with different pathologies (mainly encephalitis, zoster and varicella) by sequencing three fragments within ORF 22, ORF 21 and ORF 50 and, subsequently analyzing 7 relevant SNPs. RESULTS Among these 294 patients, 132(44.9%) patients were infected by clade 1, 42(14.3%) patients by clade 3, 19(6.5%) by clade 5, 29(9.9%) by clade VI and 3(1%) by clade 4. Four patients (1.4%) were infected by clade 2 vOKA strains, who received one dose of live-attenuated varicella vaccine. Putative recombinant clade 1/3 was identified in 6 cases (2.0%). Results obtained from partial sequences were assigned to clade 1 or 3 in 56(19%) patients and clade 5 or VI in 3(1.0%) patients. In the multivariate analysis, encephalitis was independently associated with clades 1 and 3 and age >14y.o. (P = 0.035 and P = 0.021, respectively). Additionally, Madrid had significant fewer cases of encephalitis compared with the rest of regions analyzed (P = 0.001). CONCLUSIONS Higher prevalence of clades 1 and 3 and their relation with encephalitis and age >14y.o. suggest earlier introduction of this clades in Spain. Putative interclade 1 and 3 recombinants are circulating in patients with encephalitis, herpes zoster and varicella. Several cases were related to vOKA vaccination but vaccine strains do not seem to circulate in the general population.
Collapse
Affiliation(s)
- Irene González
- Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, Majadahonda, Spain
| | - Alejandro Molina-Ortega
- Instituto de Biomedicina de Sevilla (IBIS)/CSIC/University of Sevilla, University Hospital Virgen del Rocío. Sevilla, Spain
| | - Pilar Pérez-Romero
- Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, Majadahonda, Spain
| | - Juan E Echevarría
- Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, Majadahonda, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Lante He
- Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, Majadahonda, Spain
| | - David Tarragó
- Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III, Majadahonda, Spain.
| |
Collapse
|
28
|
Aguilar-Eseiza N, Ramos-Sánchez G, González F, González I. High voltage – Improved reversible capacity in Ni+2/+3 modified copper-based cathodes for lithium ion batteries. Electrochem commun 2018. [DOI: 10.1016/j.elecom.2018.09.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
|
29
|
Nandy S, Chapman W, Rais R, González I, Chatterjee D, Mutch M, Zhu Q. Label-free quantitative optical assessment of human colon tissue using spatial frequency domain imaging. Tech Coloproctol 2018; 22:617-621. [PMID: 30159628 DOI: 10.1007/s10151-018-1841-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/27/2018] [Accepted: 08/08/2018] [Indexed: 01/16/2023]
Affiliation(s)
- S Nandy
- Department of Biomedical Engineering, Washington University, St. Louis, MO, USA
| | - W Chapman
- Department of Surgery, Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, MO, USA
| | - R Rais
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
| | - I González
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
| | - D Chatterjee
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
| | - M Mutch
- Department of Surgery, Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, MO, USA
| | - Q Zhu
- Department of Biomedical Engineering, Washington University, St. Louis, MO, USA.
- Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
| |
Collapse
|
30
|
Juarez-Yescas C, Ramos-Sánchez G, González I. Influence of reduced graphene oxides (rGO) at different reduction stages as conductive additive in Li-ion batteries. J Solid State Electrochem 2018. [DOI: 10.1007/s10008-018-4021-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
31
|
González I, Sosa AN, Trejo A, Calvino M, Miranda A, Cruz-Irisson M. Lithium effect on the electronic properties of porous silicon for energy storage applications: a DFT study. Dalton Trans 2018; 47:7505-7514. [PMID: 29789836 DOI: 10.1039/c8dt00355f] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Theoretical studies on the effect of Li on the electronic properties of porous silicon are still scarce; these studies could help us in the development of Li-ion batteries of this material which overcomes some limitations that bulk silicon has. In this work, the effect of interstitial and surface Li on the electronic properties of porous Si is studied using the first-principles density functional theory approach and the generalised gradient approximation. The pores are modeled by removing columns of atoms of an otherwise perfect Si crystal, dangling bonds of all surfaces are passivated with H atoms, and then Li is inserted on interstitial positions on the pore wall and compared with the replacement of H atoms with Li. The results show that the interstitial Li creates effects similar to n-type doping where the Fermi level is shifted towards the conduction band with band crossings of the said level thus acquiring metallic characteristics. The surface Li introduces trap-like states in the electronic band structures which increase as the number of Li atom increases with a tendency to become metallic. These results could be important for the application of porous Si nanostructures in Li-ion batteries technology.
Collapse
Affiliation(s)
- I González
- Instituto Politécnico Nacional, Seccion de estudios de posgrado e investigación, ESIME Culhuacán, Av. Santa Ana 1000, San Francisco Culhuacán, Coyoacán, Ciudad de México, Mexico.
| | | | | | | | | | | |
Collapse
|
32
|
Palma-Goyes R, Vazquez-Arenas J, Ostos C, Manzo-Robledo A, Romero-Ibarra I, Calderón J, González I. In search of the active chlorine species on Ti/ZrO2-RuO2-Sb2O3 anodes using DEMS and XPS. Electrochim Acta 2018. [DOI: 10.1016/j.electacta.2018.04.114] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
33
|
Abstract
We used diode laser photocoagulation to treat 22 eyes of 12 patients with retinopathy of prematurity. Three infants were followed for at least six months and nine for at least one year. We treated 14 eyes with threshold disease and 8 eyes with prethreshold disease. The treatment was administered within 72 hours of diagnosis and topical anesthesia and sedation were used. No evidence of lesions of the anterior segment of preretinal or vitreous hemorrhages was found after the treatment. External inflammatory signs were neglibible. Systemic complications occurred only in three treatment sessions. Eight of the 14 eyes with threshold disease (57%) and all eight eyes with prethreshold disease had favorable outcomes. In total 73% with ROP had favorable outcomes. Treatment with the diode laser is easily performed, effective essentially in cases of prethreshold disease but in threshold disease too, with minimal ocular or systemic complications.
Collapse
Affiliation(s)
- I González
- Service of Ophthalmology, Hospital Infantil Miguel Servet, Zaragoza, Spain
| | | | | | | | | | | |
Collapse
|
34
|
Pablo LE, Ramírez T, Alvarez R, González I, Larrosa JM, Honrubia FM. Morphometric Study of Wound Healing in a Model of Filtering Surgery with Mitomycin-C. Eur J Ophthalmol 2018; 5:168-71. [PMID: 8845684 DOI: 10.1177/112067219500500304] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Background Failure of filtering surgery may be related to excessive wound healing in the surgical area. This effect diminishes with the use of antimetabolic agents. Mitomycin-C (MMC) has proved to be the most effective drug to reduce myofibroblastic proliferation in experimental in vivo and in vitro models. To our knowledge, the objective changes induced by mitomycin-C in the size of wound healing areas have not been investigated. Methods: Filtering surgery was performed on both eyes of 40 pigmented rabbits. Preoperatively one of the eyes received MMC (0.5 mg/ml), and the fellow eye received balance salt solution as placebo. Animals were killed on days 6, 15, 30 and 58. Microscopic healing areas were measured by digital procedures. The areas of target and fellow control eyes were compared by the Wilcoxon test. Results This study showed significant differences (p<0.05) between treated and untreated groups, the healing are a gradually becoming smaller. Conclusions Objective methods to quantify the microscopic effects of MMC can be useful to improve our knowledge about the action on this antimetabolite and to enable us to adjust more accurately the timing and dosage when applying the drug in glaucoma filtering surgery.
Collapse
Affiliation(s)
- L E Pablo
- Department of Ophthalmology, Hospital Miguel Servet, Zaragoza, Spain
| | | | | | | | | | | |
Collapse
|
35
|
Oliver-Tolentino M, González M. M, Osiry H, Ramos-Sánchez G, González I. Electronic density distribution of Mn–N bonds by a tuning effect through partial replacement of Mn by Co or Ni in a sodium-rich hexacyanoferrate and its influence on the stability as a cathode for Na-ion batteries. Dalton Trans 2018; 47:16492-16501. [DOI: 10.1039/c8dt03595d] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
This study evaluates the effect of equimolar substitution of manganese by cobalt or nickel in hexacyanoferrate open frameworks as electrode for Na-ion batteries.
Collapse
Affiliation(s)
- M. Oliver-Tolentino
- Departamento de Química
- Universidad Autónoma Metropolitana
- Ciudad de México
- Mexico
- Centro de investigación en Ciencia Aplicada y Tecnología Avanzada
| | - M. González M.
- Centro de investigación en Ciencia Aplicada y Tecnología Avanzada
- Instituto Politécnico Nacional
- Ciudad de México
- Mexico
| | - H. Osiry
- Centro de investigación en Ciencia Aplicada y Tecnología Avanzada
- Instituto Politécnico Nacional
- Ciudad de México
- Mexico
| | - G. Ramos-Sánchez
- Departamento de Química
- Universidad Autónoma Metropolitana
- Ciudad de México
- Mexico
| | - I. González
- Departamento de Química
- Universidad Autónoma Metropolitana
- Ciudad de México
- Mexico
| |
Collapse
|
36
|
González I, Pascual J, Corona D, Hispán P, Betlloch I. European Heart Systemic Coronary Risk Evaluation may underestimate cardiovascular risk after assessing cardiovascular disease with carotid ultrasound in hidradenitis suppurativa. Br J Dermatol 2017; 178:e22-e23. [DOI: 10.1111/bjd.15776] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- I. González
- Department of Dermatology Alicante University General Hospital Alicante Institute for Health and Biomedical Research (ISABIAL‐FISABIO Foundation) Alicante Spain
| | - J.C. Pascual
- Department of Dermatology Alicante University General Hospital Alicante Institute for Health and Biomedical Research (ISABIAL‐FISABIO Foundation) Alicante Spain
| | - D. Corona
- Department of Neurology Alicante University General Hospital Alicante Institute for Health and Biomedical Research (ISABIAL‐FISABIO Foundation) Alicante Spain
| | - P. Hispán
- Department of Dermatology Alicante University General Hospital Alicante Institute for Health and Biomedical Research (ISABIAL‐FISABIO Foundation) Alicante Spain
| | - I. Betlloch
- Department of Dermatology Alicante University General Hospital Alicante Institute for Health and Biomedical Research (ISABIAL‐FISABIO Foundation) Alicante Spain
| |
Collapse
|
37
|
Georgousaki K, Katsinas N, Tsafantakis N, Gumeni S, Oves-Costales D, González I, Almeida C, Genilloud O, Trougakos IP, Fokialakis N. Actinobacteria of global biodiversity as a source of bioactive metabolites for the discovery and development of novel cosmeuceutical agents. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- K Georgousaki
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - N Katsinas
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - N Tsafantakis
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - S Gumeni
- Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | | | | | - IP Trougakos
- Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | - N Fokialakis
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
38
|
Georgousaki K, Tsafantakis N, Cheilari A, Gumeni S, González I, González V, Tormo José R, Genilloud O, Foteinos S, Trougakos I, Fokialakis N. Discovery of novel cosmeuceutical agents from endophytic microorganisms of Spanish biodiversity. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- K Georgousaki
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - N Tsafantakis
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | | | - S Gumeni
- Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | | | | | | | - I Trougakos
- Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | - N Fokialakis
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
39
|
Peyrat LA, Georgousaki K, Tsafantakis N, Gumeni S, Oves-Costales D, González I, Almeida C, Genilloud O, Trougakos IP, Fokialakis N. Search for novel cosmeuceutical agents from the Actinobacteria Micromonospora sp. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- LA Peyrat
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - K Georgousaki
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - N Tsafantakis
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - S Gumeni
- Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | | | | | - IP Trougakos
- Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | - N Fokialakis
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
40
|
Guzmán G, Vazquez-Arenas J, Ramos-Sánchez G, Bautista-Ramírez M, González I. Improved performance of LiFePO4 cathode for Li-ion batteries through percolation studies. Electrochim Acta 2017. [DOI: 10.1016/j.electacta.2017.06.172] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
41
|
Capistrano-Gossmann GG, Ries D, Holtgräwe D, Minoche A, Kraft T, Frerichmann SLM, Rosleff Soerensen T, Dohm JC, González I, Schilhabel M, Varrelmann M, Tschoep H, Uphoff H, Schütze K, Borchardt D, Toerjek O, Mechelke W, Lein JC, Schechert AW, Frese L, Himmelbauer H, Weisshaar B, Kopisch-Obuch FJ. Crop wild relative populations of Beta vulgaris allow direct mapping of agronomically important genes. Nat Commun 2017; 8:15708. [PMID: 28585529 PMCID: PMC5467160 DOI: 10.1038/ncomms15708] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Accepted: 04/21/2017] [Indexed: 01/13/2023] Open
Abstract
Rapid identification of agronomically important genes is of pivotal interest for crop breeding. One source of such genes are crop wild relative (CWR) populations. Here we used a CWR population of <200 wild beets (B. vulgaris ssp. maritima), sampled in their natural habitat, to identify the sugar beet (Beta vulgaris ssp. vulgaris) resistance gene Rz2 with a modified version of mapping-by-sequencing (MBS). For that, we generated a draft genome sequence of the wild beet. Our results show the importance of preserving CWR in situ and demonstrate the great potential of CWR for rapid discovery of causal genes relevant for crop improvement. The candidate gene for Rz2 was identified by MBS and subsequently corroborated via RNA interference (RNAi). Rz2 encodes a CC-NB-LRR protein. Access to the DNA sequence of Rz2 opens the path to improvement of resistance towards rhizomania not only by marker-assisted breeding but also by genome editing. Variation among wild relatives of crop plants can be used to identify genes underlying traits of agronomic importance. Here, the authors show that a modified mapping-by-sequencing approach can rapidly identify the genetic basis for viral resistance in sugar beet using wild beet populations in their natural habitat.
Collapse
Affiliation(s)
| | - D Ries
- CeBiTec &Faculty of Biology, Bielefeld University, Universitätsstraße 25, Bielefeld 33615, Germany
| | - D Holtgräwe
- CeBiTec &Faculty of Biology, Bielefeld University, Universitätsstraße 25, Bielefeld 33615, Germany
| | - A Minoche
- Max Planck Institute for Molecular Genetics, Ihnestraße 73, Berlin 14195, Germany.,Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney NSW 2010, Australia
| | - T Kraft
- Syngenta Seeds AB, Box 302, Landskrona 26123, Sweden
| | - S L M Frerichmann
- Plant Breeding Institute, Kiel University, Am Botanischen Garten 1-9, Kiel 24118, Germany
| | - T Rosleff Soerensen
- CeBiTec &Faculty of Biology, Bielefeld University, Universitätsstraße 25, Bielefeld 33615, Germany
| | - J C Dohm
- Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Muthgasse 18, 1190 Vienna, Austria
| | - I González
- Centre for Genomic Regulation (CRG), Carrer del Dr. Aiguader 88, Barcelona 08003, Spain
| | - M Schilhabel
- Plant Breeding Institute, Kiel University, Am Botanischen Garten 1-9, Kiel 24118, Germany
| | - M Varrelmann
- Department of Phytopathology, Institute of Sugar Beet Research (IfZ), Holtenser Landstraße 77, Göttingen 37079, Germany
| | - H Tschoep
- SESVanderHave N.V., Industriepark, Tienen 3300, Belgium
| | - H Uphoff
- Syngenta Seeds AB, Box 302, Landskrona 26123, Sweden
| | - K Schütze
- KWS SAAT SE, Grimsehlstraße 31, Einbeck 37555, Germany
| | - D Borchardt
- KWS SAAT SE, Grimsehlstraße 31, Einbeck 37555, Germany
| | - O Toerjek
- KWS SAAT SE, Grimsehlstraße 31, Einbeck 37555, Germany
| | - W Mechelke
- KWS SAAT SE, Grimsehlstraße 31, Einbeck 37555, Germany
| | - J C Lein
- KWS SAAT SE, Grimsehlstraße 31, Einbeck 37555, Germany
| | - A W Schechert
- Strube Research GmbH &Co. KG, Hauptstraße 1, Söllingen 38387, Germany
| | - L Frese
- Federal Research Centre for Cultivated Plants (JKI), Erwin-Baur-Str. 27, Quedlinburg 06484, Germany
| | - H Himmelbauer
- Max Planck Institute for Molecular Genetics, Ihnestraße 73, Berlin 14195, Germany.,Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Muthgasse 18, 1190 Vienna, Austria.,Centre for Genomic Regulation (CRG), Carrer del Dr. Aiguader 88, Barcelona 08003, Spain
| | - B Weisshaar
- CeBiTec &Faculty of Biology, Bielefeld University, Universitätsstraße 25, Bielefeld 33615, Germany
| | - F J Kopisch-Obuch
- Plant Breeding Institute, Kiel University, Am Botanischen Garten 1-9, Kiel 24118, Germany.,KWS SAAT SE, Grimsehlstraße 31, Einbeck 37555, Germany
| |
Collapse
|
42
|
Hidalgo M, Álvarez R, Gallego J, Guillén-Ponce C, Laquente B, Macarulla T, Muñoz A, Salgado M, Vera R, Adeva J, Alés I, Arévalo S, Blázquez J, Calsina A, Carmona A, de Madaria E, Díaz R, Díez L, Fernández T, de Paredes BG, Gallardo ME, González I, Hernando O, Jiménez P, López A, López C, López-Ríos F, Martín E, Martínez J, Martínez A, Montans J, Pazo R, Plaza JC, Peiró I, Reina JJ, Sanjuanbenito A, Yaya R, Carrato A. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain. Clin Transl Oncol 2017; 19:667-681. [PMID: 27995549 PMCID: PMC5427095 DOI: 10.1007/s12094-016-1594-x] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2016] [Accepted: 11/24/2016] [Indexed: 12/12/2022]
Abstract
The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended.
Collapse
Affiliation(s)
- M Hidalgo
- Spanish National Cancer Centre, C/Melchor Fernández Almagro, 3, 28029, Madrid, Spain.
- Beth Israel Deaconess Medical Center, Boston, USA.
| | - R Álvarez
- Department of Medical Oncology, Centro Integral Oncológico Clara Campal, Madrid, Spain
| | - J Gallego
- University Hospital of Elche, Elche, Spain
| | - C Guillén-Ponce
- Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo km. 9,100, 28034, Madrid, Spain
| | - B Laquente
- Institut Català d´Oncologia, Duran y Reynals Hospital, Hospitalet Llobregat, Barcelona, Spain
| | - T Macarulla
- Vall d'Hebrón University Hospital, Barcelona, Spain
| | - A Muñoz
- University Hospital Gregorio Marañón, Madrid, Spain
| | - M Salgado
- University Hospital of Ourense, Ourense, Spain
| | - R Vera
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - J Adeva
- University Hospital 12 de Octubre, Madrid, Spain
| | - I Alés
- Hospital Carlos Haya, Málaga, Spain
| | - S Arévalo
- University Hospital Donostia, San Sebastián, Spain
| | - J Blázquez
- Department of Radiology, University Hospital Ramón y Cajal, Madrid, Spain
- MD Anderson Hospital, Madrid, Spain
| | - A Calsina
- Department of Palliative Care, Hospital Germans Trias I Pujol, Institut Catalá d´Oncologia, Badalona, Spain
| | - A Carmona
- Department of Medical Oncology and Hematology, University Hospital Morales Messeguer, Murcia, Spain
| | - E de Madaria
- Department of Gastroenterology, Hospital General Universitario de Alicante, Alicante, Spain
| | - R Díaz
- Department of Medical Oncology, Hospital Universitari I Politècnic La Fe, Valencia, Spain
| | - L Díez
- Department of Surgery, Hospital Clínico San Carlos, Madrid, Spain
| | - T Fernández
- Department of Medical Oncology, Hospital Son Llàtzer, Palma de Mallorca, Spain
| | | | - M E Gallardo
- Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain
| | - I González
- Complejo Hospitalario de Granada, Granada, Spain
| | - O Hernando
- Department of Radiotherapy, University Hospital HM Sanchinarro, Madrid, Spain
- University Hospital HM Puerta del Sur, Madrid, Spain
| | - P Jiménez
- Department of Medical Oncology, Hospital Universitario Central de Asturias, Asturias, Spain
| | - A López
- Hospital Universitario de Burgos, Burgos, Spain
| | - C López
- Hospital Universitario Marqués de Valdecilla, Santander, Spain
| | - F López-Ríos
- Department of Pathology, University Hospital HM Sanchinarro, Madrid, Spain
| | - E Martín
- Department of Surgery, Hospital Universitario de la Princesa, Madrid, Spain
| | - J Martínez
- Department of Medical Oncology, University Hospital Virgen de las Nieves, Granada, Spain
| | | | - J Montans
- Department of Pathology, Centro Anatomopatológico, Madrid, Spain
| | - R Pazo
- Department of Medical Oncology, University Hospital Miguel Servet, Saragossa, Spain
| | - J C Plaza
- Department of Pathology, University Hospital HM Sanchinarro, Madrid, Spain
| | - I Peiró
- Department of Endocrinology, Instituto Catalán de Oncología, Hospital Duran I Reynals, Hospitalet de Llobregat, Barcelona, Spain
| | - J J Reina
- Department of Medical Oncology, University Hospital Virgen de la Macarena, Seville, Spain
| | - A Sanjuanbenito
- Department of Surgery, University Hospital Ramón y Cajal, Madrid, Spain
| | - R Yaya
- Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain
| | - Alfredo Carrato
- Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo km. 9,100, 28034, Madrid, Spain.
| |
Collapse
|
43
|
Lahera G, Cid J, González-Pinto A, Cabrera A, González I, Vieta E, Arango C, Crespo-Facorro B. Needs of People with Schizophrenia/Psychosis and their Caregivers: A Large Scale Survey. Eur Psychiatry 2017. [DOI: 10.1016/j.eurpsy.2017.01.302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
For the first time in Spain, a large scale survey (5205 people) was carried out to establish the real needs of those directly affected by the illness. Patients and caregivers responded to a 9-question survey concerning dimensions: personal, social, medical treatment, psychotherapy and rehabilitation. For patients, the most important need (an average score of 3.5 on a scale of importance from 1 to 4) was to feel their emotional needs covered. The following average scores were also obtained: feel well physically (3.42), improve autonomy (3.41), have leisure activities (3.21) and work/study (3.1). A total of 42% of patients indicated having little or no freedom over their lives. Thirty-six percent indicated that medical treatment did not start soon enough, 35% that psychotherapy started too late and 13% saying they had received no psychotherapy at all. The help from professionals most valued was provide information about the illness (3.4), dedicating more time (3.4) investigating new treatments (3.3) paying attention to secondary effects (3.3) and incorporating the patient in decision making (3.3). Most patients reported a state of health “regular to good” but 10% indicated not being understood at all in their social environment since onset of illness and 25% being little understood. The anti-stigma initiative most valued was to increase investment in schizophrenia in health planning. Integral health planning should incorporate patient insights concerning basic needs and treatment preferences.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
44
|
González I, Pascual JC, Corona D, Hispán P, Ramos JM, Sánchez-Paya J, Jemec GB. Assessment of subclinical atherosclerosis in hidradenitis suppurativa: Reply to Dr Vinkel's letter. J Eur Acad Dermatol Venereol 2017; 31:e413-e414. [PMID: 28300331 DOI: 10.1111/jdv.14226] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- I González
- Department of Dermatology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
| | - J C Pascual
- Department of Dermatology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
| | - D Corona
- Department of Neurology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
| | - P Hispán
- Department of Dermatology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
| | - J M Ramos
- Department of Internal Medicine, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
| | - J Sánchez-Paya
- Epidemiology Unit, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
| | - G B Jemec
- Department of Dermatology, Zealand University Hospital Roskilde, Copenhagen, Denmark.,Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
45
|
Perez-Roche T, Altemir I, Giménez G, Prieto E, González I, López Pisón J, Pueyo V. Face recognition impairment in small for gestational age and preterm children. Res Dev Disabil 2017; 62:166-173. [PMID: 28171826 DOI: 10.1016/j.ridd.2017.01.016] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/18/2016] [Revised: 01/21/2017] [Accepted: 01/22/2017] [Indexed: 06/06/2023]
Abstract
BACKGROUND Infants born prematurely or with low birth weight are at increased risk of visual perceptual impairment. Face recognition is a high-order visual ability important for social development, which has been rarely assessed in premature or low birth weight children. AIMS To evaluate the influence of prematurity and low birth weight on face recognition skills. METHODS Seventy-seven children were evaluated as part of a prospective cohort study. They were divided into premature and term birth cohorts. Children with a birth weight below the 10th centile were considered small for gestational age. All children underwent a full ophthalmologic assessment and evaluation of face recognition skills using the Facial Memory subtest from the Test of Memory and Learning. RESULTS Premature infants scored worse on immediate face recognition compared to term infants. However, after adjusting for birth weight, prematurity was not associated with worse outcomes. Independent of gestational age, outcomes of low birth weight children were worse than those of appropriate birth weight children, for immediate face recognition (odds ratio [OR], 5.14; 95% confidence interval [CI], 1.32-21.74) and for face memory (OR, 4.48; 95% CI, 1.14-16.95). CONCLUSIONS Being born small for gestational age is associated with suboptimal face recognition skills, even in children without major neurodevelopmental problems.
Collapse
Affiliation(s)
- T Perez-Roche
- Instituto de Investigación Sanitaria de Aragón (ISS Aragón), Avenida San Juan Bosco 13, 50009 Zaragoza, Spain; Ophthalmology Department, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain
| | - I Altemir
- Instituto de Investigación Sanitaria de Aragón (ISS Aragón), Avenida San Juan Bosco 13, 50009 Zaragoza, Spain; Optical Optometrist, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain
| | - G Giménez
- Instituto de Investigación Sanitaria de Aragón (ISS Aragón), Avenida San Juan Bosco 13, 50009 Zaragoza, Spain; Optical Optometrist, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain
| | - E Prieto
- Instituto de Investigación Sanitaria de Aragón (ISS Aragón), Avenida San Juan Bosco 13, 50009 Zaragoza, Spain; Ophthalmology Department, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain
| | - I González
- Instituto de Investigación Sanitaria de Aragón (ISS Aragón), Avenida San Juan Bosco 13, 50009 Zaragoza, Spain; Ophthalmology Department, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain
| | - J López Pisón
- Instituto de Investigación Sanitaria de Aragón (ISS Aragón), Avenida San Juan Bosco 13, 50009 Zaragoza, Spain; Child Neurology Unit, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain
| | - V Pueyo
- Instituto de Investigación Sanitaria de Aragón (ISS Aragón), Avenida San Juan Bosco 13, 50009 Zaragoza, Spain; Ophthalmology Department, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain.
| |
Collapse
|
46
|
Pascual J, González I, Corona D, Hispán P, Ramos J, Sánchez-Paya J, Jemec G. Assessment of subclinical atherosclerosis in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2017; 31:1229-1238. [DOI: 10.1111/jdv.14076] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Accepted: 11/23/2016] [Indexed: 01/02/2023]
Affiliation(s)
- J.C. Pascual
- Department of Dermatology; Alicante University General Hospital; Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation); Alicante Spain
| | - I. González
- Department of Dermatology; Alicante University General Hospital; Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation); Alicante Spain
| | - D. Corona
- Department of Neurology; Alicante University General Hospital; Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation); Alicante Spain
| | - P. Hispán
- Department of Dermatology; Alicante University General Hospital; Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation); Alicante Spain
| | - J.M. Ramos
- Department of Internal Medicine; Alicante University General Hospital; Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation); Alicante Spain
| | - J. Sánchez-Paya
- Epidemiology Unit; Alicante University General Hospital; Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation); Alicante Spain
| | - G.B. Jemec
- Department of Dermatology; Zealand University Hospital Roskilde; Health Sciences Faculty; University of Copenhagen; Copenhagen Denmark
| |
Collapse
|
47
|
van Andel L, Fudio S, Rosing H, Munt S, Miguel-Lillo B, González I, Tibben MM, de Vries N, de Vries Schultink AHM, Schellens JHM, Beijnen JH. Pharmacokinetics and excretion of 14C-Plitidepsin in patients with advanced cancer. Invest New Drugs 2017; 35:589-598. [PMID: 28111728 DOI: 10.1007/s10637-017-0432-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2016] [Accepted: 01/16/2017] [Indexed: 12/11/2022]
Abstract
Plitidepsin (Aplidin®) is a marine-derived anticancer compound currently investigated in phase III clinical trials. This article describes the distribution, metabolism and excretion of this novel agent and it mainly aims to identify the major routes of elimination. Six subjects were enrolled in a mass balance study during which radiolabelled plitidepsin was administered as a 3-h intravenous infusion. Blood samples were taken and urine and faeces were collected. Total radioactivity (TRA) analysis using Liquid Scintillation Counting (LSC) was done to determine the amount of radioactivity excreted from the body and plitidepsin concentrations in whole blood, plasma and urine were determined by validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays. In total, a mean of 77.4% of the administered radioactivity was excreted over a time period of 20 days, of which 71.3% was recovered in faeces and 6.1% was found in urine. The majority excreted in urine was accounted for by unchanged plitidepsin, with only 1.5% of the total administered dose explained by metabolites in urine. Faeces, on the other hand contained low levels of parent compound, which means that most of the TRA excreted in faeces was accounted for by metabolites. TRA levels were 3.7 times higher in whole blood compared to plasma. Plitidepsin was widely distributed and plasma clearance was low. This study shows that red blood cells are a major distribution compartment and that the biliary route is the main route of total radioactivity excretion.
Collapse
Affiliation(s)
- L van Andel
- Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek / The Netherlands Cancer Institute, P.O. Box 90440, 1006, BK, Amsterdam, The Netherlands.
| | - S Fudio
- Pharma Mar, S.A. Colmenar Viejo, Madrid, Spain
| | - H Rosing
- Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek / The Netherlands Cancer Institute, P.O. Box 90440, 1006, BK, Amsterdam, The Netherlands
| | - S Munt
- Pharma Mar, S.A. Colmenar Viejo, Madrid, Spain
| | | | - I González
- Pharma Mar, S.A. Colmenar Viejo, Madrid, Spain
| | - M M Tibben
- Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek / The Netherlands Cancer Institute, P.O. Box 90440, 1006, BK, Amsterdam, The Netherlands
| | - N de Vries
- Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek / The Netherlands Cancer Institute, P.O. Box 90440, 1006, BK, Amsterdam, The Netherlands
| | - A H M de Vries Schultink
- Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek / The Netherlands Cancer Institute, P.O. Box 90440, 1006, BK, Amsterdam, The Netherlands
| | - J H M Schellens
- Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.,Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
| | - J H Beijnen
- Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek / The Netherlands Cancer Institute, P.O. Box 90440, 1006, BK, Amsterdam, The Netherlands.,Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
| |
Collapse
|
48
|
Abstract
The significant increase in the prevalence of obesity has led to an increase in the number of obese women who become pregnant. In this setting, in recent years, there has been an exponential rise in the number of bariatric procedures, with approximately half of them performed in women of childbearing age, and a remarkable surge in the number of women who become pregnant after having undergone bariatric surgery (BS). These procedures entail the risk of nutritional deficiencies, and nutrition is a crucial aspect during pregnancy. Therefore, knowledge and awareness of the consequences of these techniques on maternal and fetal outcomes is essential. Current evidence suggests a better overall obstetric outcome after BS, in comparison to morbid obese women managed conservatively, with a reduction in the prevalence of gestational diabetes mellitus, pregnancy-associated hypertensive disorders, macrosomia, and congenital defects. However, the risk of potential maternal nutritional deficiencies and newborns small for gestational age cannot be overlooked. Results concerning the incidence of preterm delivery and the number of C-sections are less consistent. In this paper, we review the updated evidence regarding the impact of BS on pregnancy.
Collapse
Affiliation(s)
- Irene González
- Endocrinology and Nutrition Department, Complejo Hospitalario Universitario de Huelva, Huelva, Spain
| | - Albert Lecube
- Endocrinology and Nutrition Department, Arnau de Vilanova University Hospital, Lleida Biomedicine Research Institute (IRB-Lleida), CIBER in Diabetes and Associated Metabolic Disorders (CIBERDEM), Lleida University, Lleida, Spain
| | - Miguel Ángel Rubio
- Endocrinology and Nutrition Department, Hospital Clínico San Carlos, IDISSC, Madrid, Spain
| | - Pedro Pablo García-Luna
- Endocrinology and Nutrition Department, Hospitales Universitarios Virgen del Rocío, Seville, Spain
| |
Collapse
|
49
|
Perez-Roche T, Altemir I, Giménez G, Prieto E, González I, Peña-Segura JL, Castillo O, Pueyo V. Effect of prematurity and low birth weight in visual abilities and school performance. Res Dev Disabil 2016; 59:451-457. [PMID: 27744269 DOI: 10.1016/j.ridd.2016.10.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/17/2016] [Revised: 09/13/2016] [Accepted: 10/04/2016] [Indexed: 06/06/2023]
Abstract
BACKGROUND Prematurity and low birth weight are known risk factors for cognitive and developmental impairments, and school failure. Visual perceptual and visual motor skills seem to be among the most affected cognitive domains in these children. AIMS To assess the influence of prematurity and low birth weight in visual cognitive skills and school performance. METHODS We performed a prospective cohort study, which included 80 boys and girls in an age range from 5 to 13. Subjects were grouped by gestational age at birth (preterm, <37 weeks; term, 37-42 weeks) and birth weight (small for gestational age (SGA), <10th centile; appropriate weight for gestational age (AGA), ≥10th centile). Each child underwent full ophthalmologic assessment and standardized testing of visual cognitive abilities (Test of Visual Perceptual Skills and Test of Visual Analysis Skills). Parents completed a questionnaire on school performance in children. RESULTS Figure-ground skill and visual motor integration were significantly decreased in the preterm birth group, compared with term control subjects (figure-ground: 45.7 vs 66.5, p=0.012; visual motor integration, TVAS: (9.9 vs 11.8, p=0.018), while outcomes of visual memory (29.0 vs 47.7, p=0.012), form constancy (33.3 vs 52.8, p=0.019), figure-ground (37.4 vs 65.6, p=0.001), and visual closure (43.7 vs 62.6 p=0.016) testing were lower in the SGA (vs AGA) group. Visual cognitive difficulties corresponded with worse performance in mathematics (r=0.414, p=0.004) and reading (r=0.343, p=0.018). CONCLUSION Specific patterns of visual perceptual and visual motor deficits are displayed by children born preterm or SGA, which hinder mathematics and reading performance.
Collapse
Affiliation(s)
- T Perez-Roche
- Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Ophthalmology Department, Paediatric Ophthalmology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - I Altemir
- Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Ophthalmology Department, Paediatric Ophthalmology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - G Giménez
- Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Ophthalmology Department, Paediatric Ophthalmology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - E Prieto
- Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Ophthalmology Department, Paediatric Ophthalmology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - I González
- Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Ophthalmology Department, Paediatric Ophthalmology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - J L Peña-Segura
- Child Neurology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - O Castillo
- Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Ophthalmology Department, Paediatric Ophthalmology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - V Pueyo
- Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Ophthalmology Department, Paediatric Ophthalmology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain; Red de Salud Materno Infantil y Desarrollo - SAMID, Spain.
| |
Collapse
|
50
|
González I, Barba-Brioso C, Campos P, Romero A, Galán E. Reduction of CO2 diffuse emissions from the traditional ceramic industry by the addition of Si-Al raw material. J Environ Manage 2016; 180:190-196. [PMID: 27233044 DOI: 10.1016/j.jenvman.2016.05.039] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2016] [Revised: 04/18/2016] [Accepted: 05/14/2016] [Indexed: 06/05/2023]
Abstract
The fabrication of ceramics can produce the emission of several gases, denominated exhaust gases, and also vapours resulting from firing processes, which usually contain metals and toxic substances affecting the environment and the health of workers. Especially harmful are the diffuse emissions of CO2, fluorine, chlorine and sulphur from the ceramics industry, which, in highly industrialized areas, can suppose an important emission focus of dangerous effects. Concerning CO2, factories that use carbonate-rich raw materials (>30% carbonates) can emit high concentrations of CO2 to the atmosphere. Thus, carbonate reduction or substitution with other raw materials would reduce the emissions. In this contribution, we propose the addition of Al-shales to the carbonated ceramic materials (marls) for CO2 emission reduction, also improving the quality of the products. The employed shales are inexpensive materials of large reserves in SW-Spain. The ceramic bodies prepared with the addition of selected Al-shale to marls in variable proportions resulted in a 40%-65% CO2 emission reduction. In addition, this research underlines at the same time that the use of a low-price raw material can also contribute to obtaining products with higher added value.
Collapse
Affiliation(s)
- I González
- Departamento de Cristalografía, Mineralogía y Química Agrícola, Facultad de Química, Universidad de Sevilla, 41012 Seville, Spain.
| | - C Barba-Brioso
- Departamento de Cristalografía, Mineralogía y Química Agrícola, Facultad de Química, Universidad de Sevilla, 41012 Seville, Spain.
| | - P Campos
- Departamento de Cristalografía, Mineralogía y Química Agrícola, Facultad de Química, Universidad de Sevilla, 41012 Seville, Spain.
| | - A Romero
- Departamento de Cristalografía, Mineralogía y Química Agrícola, Facultad de Química, Universidad de Sevilla, 41012 Seville, Spain.
| | - E Galán
- Departamento de Cristalografía, Mineralogía y Química Agrícola, Facultad de Química, Universidad de Sevilla, 41012 Seville, Spain.
| |
Collapse
|